CN102548976A - 作为s1p调节剂的(硫)吗啉衍生物 - Google Patents
作为s1p调节剂的(硫)吗啉衍生物 Download PDFInfo
- Publication number
- CN102548976A CN102548976A CN2010800426818A CN201080042681A CN102548976A CN 102548976 A CN102548976 A CN 102548976A CN 2010800426818 A CN2010800426818 A CN 2010800426818A CN 201080042681 A CN201080042681 A CN 201080042681A CN 102548976 A CN102548976 A CN 102548976A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- morpholine
- propionic acid
- chloro
- benzyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GNPPFOLOFVAMQJ-UHFFFAOYSA-N morpholine-2-thiol Chemical class SC1CNCCO1 GNPPFOLOFVAMQJ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 278
- -1 phenoxy, benzyl Chemical group 0.000 claims abstract description 163
- 150000003839 salts Chemical class 0.000 claims abstract description 119
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 73
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 41
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 18
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 14
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims abstract description 13
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 12
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 12
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 11
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 10
- 150000002367 halogens Chemical class 0.000 claims abstract description 10
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims abstract description 8
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 6
- 125000002619 bicyclic group Chemical group 0.000 claims abstract description 5
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims abstract description 5
- BKAUQERDADHUJA-UHFFFAOYSA-N 2-[4-[4-(2-hydroxyethyl)morpholin-2-yl]phenyl]acetonitrile Chemical compound C1N(CCO)CCOC1C1=CC=C(CC#N)C=C1 BKAUQERDADHUJA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims abstract description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims abstract description 4
- 125000005843 halogen group Chemical group 0.000 claims abstract description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims abstract description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 214
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 200
- 239000000460 chlorine Substances 0.000 claims description 77
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 229910052760 oxygen Inorganic materials 0.000 claims description 39
- 239000001301 oxygen Substances 0.000 claims description 39
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 25
- 125000000068 chlorophenyl group Chemical group 0.000 claims description 21
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 16
- 229910052801 chlorine Inorganic materials 0.000 claims description 15
- 208000010877 cognitive disease Diseases 0.000 claims description 15
- 102100029802 Sphingosine 1-phosphate receptor 5 Human genes 0.000 claims description 14
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 13
- 229910052794 bromium Inorganic materials 0.000 claims description 13
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 12
- 101710155451 Sphingosine 1-phosphate receptor 5 Proteins 0.000 claims description 12
- 229910052731 fluorine Inorganic materials 0.000 claims description 12
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 239000000556 agonist Substances 0.000 claims description 10
- 239000011737 fluorine Substances 0.000 claims description 10
- 125000004803 chlorobenzyl group Chemical group 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 125000001118 alkylidene group Chemical group 0.000 claims description 8
- 230000006999 cognitive decline Effects 0.000 claims description 8
- XLJMAIOERFSOGZ-UHFFFAOYSA-N cyanic acid Chemical compound OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 229920002554 vinyl polymer Polymers 0.000 claims description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 7
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 7
- 239000005864 Sulphur Substances 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- IMOUNGXRXHGDRH-UHFFFAOYSA-N 2-[2-(4-octoxyphenyl)morpholin-4-yl]ethanol Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCO)C1 IMOUNGXRXHGDRH-UHFFFAOYSA-N 0.000 claims description 4
- AKVHWTNCLHULGW-UHFFFAOYSA-N 2-[2-(4-octoxyphenyl)morpholin-4-yl]ethylphosphonic acid Chemical class C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCP(O)(O)=O)C1 AKVHWTNCLHULGW-UHFFFAOYSA-N 0.000 claims description 4
- 208000002193 Pain Diseases 0.000 claims description 4
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 4
- 125000005605 benzo group Chemical group 0.000 claims description 4
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- 125000001425 triazolyl group Chemical group 0.000 claims description 4
- 230000002792 vascular Effects 0.000 claims description 4
- DNHIRJUIYPFOGA-UHFFFAOYSA-N 3-[2-(4-octoxyphenyl)morpholin-4-yl]-3-oxopropanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(C(=O)CC(O)=O)C1 DNHIRJUIYPFOGA-UHFFFAOYSA-N 0.000 claims description 3
- 206010003805 Autism Diseases 0.000 claims description 3
- 208000020706 Autistic disease Diseases 0.000 claims description 3
- 208000014060 Niemann-Pick disease Diseases 0.000 claims description 3
- PCPUGIVXHJXZMM-UHFFFAOYSA-N [S].C1COCCN1 Chemical class [S].C1COCCN1 PCPUGIVXHJXZMM-UHFFFAOYSA-N 0.000 claims description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 3
- 229960003328 benzoyl peroxide Drugs 0.000 claims description 3
- 230000001149 cognitive effect Effects 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 3
- 125000004598 dihydrobenzofuryl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 3
- 125000001207 fluorophenyl group Chemical group 0.000 claims description 3
- 125000005945 imidazopyridyl group Chemical group 0.000 claims description 3
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims description 3
- 208000024714 major depressive disease Diseases 0.000 claims description 3
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims description 3
- 201000006417 multiple sclerosis Diseases 0.000 claims description 3
- 230000004770 neurodegeneration Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 201000000980 schizophrenia Diseases 0.000 claims description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 3
- CHZSIZGGQRGIIQ-UHFFFAOYSA-N 3-[2-(2-methyl-4-phenylmethoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC=C1 CHZSIZGGQRGIIQ-UHFFFAOYSA-N 0.000 claims description 2
- QORHKIDYJDUUCE-UHFFFAOYSA-N 3-[2-(4-octoxyphenyl)morpholin-4-yl]butanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(C(C)CC(O)=O)C1 QORHKIDYJDUUCE-UHFFFAOYSA-N 0.000 claims description 2
- KERCXZUQUUOOCS-UHFFFAOYSA-N 3-[2-(4-phenylmethoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=CC=C1 KERCXZUQUUOOCS-UHFFFAOYSA-N 0.000 claims description 2
- KVIRHRRVUGLELW-UHFFFAOYSA-N 3-[2-[2-methyl-4-(naphthalen-2-ylmethoxy)phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC(OCC=2C=C3C=CC=CC3=CC=2)=CC=C1C1CN(CCC(O)=O)CCO1 KVIRHRRVUGLELW-UHFFFAOYSA-N 0.000 claims description 2
- AYLWVUKIAILLDI-UHFFFAOYSA-N 3-[2-[2-methyl-4-(pyridin-2-ylmethoxy)phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC=N1 AYLWVUKIAILLDI-UHFFFAOYSA-N 0.000 claims description 2
- FQUYBLOCFDIBLV-UHFFFAOYSA-N 3-[2-[2-methyl-4-(thiophen-2-ylmethoxy)phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CS1 FQUYBLOCFDIBLV-UHFFFAOYSA-N 0.000 claims description 2
- IBEWZHRFFSJHBX-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(2,3,4-trimethoxyphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound COC1=C(OC)C(OC)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 IBEWZHRFFSJHBX-UHFFFAOYSA-N 0.000 claims description 2
- XRHCEVSALIQAEC-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(2,4,5-trimethoxyphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound COC1=CC(OC)=C(OC)C=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 XRHCEVSALIQAEC-UHFFFAOYSA-N 0.000 claims description 2
- CVKYAJYVLOAZPG-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(2-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 CVKYAJYVLOAZPG-UHFFFAOYSA-N 0.000 claims description 2
- YRAZADIFZKMMPB-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(3-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=CC(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=C1 YRAZADIFZKMMPB-UHFFFAOYSA-N 0.000 claims description 2
- ZEIUTCDZSHXROO-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(3-phenoxyphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC(C=1)=CC=CC=1OC1=CC=CC=C1 ZEIUTCDZSHXROO-UHFFFAOYSA-N 0.000 claims description 2
- XZKISWLTEKJDFB-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(3-phenylmethoxyphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 XZKISWLTEKJDFB-UHFFFAOYSA-N 0.000 claims description 2
- ZQDHLVYSRIRHHQ-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(4-phenylmethoxyphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC(C=C1)=CC=C1OCC1=CC=CC=C1 ZQDHLVYSRIRHHQ-UHFFFAOYSA-N 0.000 claims description 2
- SAQVYJVKKXRYMO-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(6-methylpyridin-2-yl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=CC(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=N1 SAQVYJVKKXRYMO-UHFFFAOYSA-N 0.000 claims description 2
- GOKVOMQVYDWUAM-UHFFFAOYSA-N 3-[2-[2-methyl-4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC=C1C(F)(F)F GOKVOMQVYDWUAM-UHFFFAOYSA-N 0.000 claims description 2
- ZSULXEDVNCUNSB-UHFFFAOYSA-N 3-[2-[2-methyl-4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC(C(F)(F)F)=C1 ZSULXEDVNCUNSB-UHFFFAOYSA-N 0.000 claims description 2
- UVTYHQHTEYQMDL-UHFFFAOYSA-N 3-[2-[2-methyl-4-[[4-(trifluoromethoxy)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=C(OC(F)(F)F)C=C1 UVTYHQHTEYQMDL-UHFFFAOYSA-N 0.000 claims description 2
- GMDYGNQNHANWHA-UHFFFAOYSA-N 3-[2-[2-methyl-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=C(C(F)(F)F)C=C1 GMDYGNQNHANWHA-UHFFFAOYSA-N 0.000 claims description 2
- CJVPKFZMISOPFC-UHFFFAOYSA-N 3-[2-[4-(2,3-dihydro-1,4-benzodioxin-3-ylmethoxy)-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC(OCC2OC3=CC=CC=C3OC2)=CC=C1C1CN(CCC(O)=O)CCO1 CJVPKFZMISOPFC-UHFFFAOYSA-N 0.000 claims description 2
- JSQALUAQEHVUDO-UHFFFAOYSA-N 3-[2-[4-[(2,3-dimethoxyphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound COC1=CC=CC(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=C1OC JSQALUAQEHVUDO-UHFFFAOYSA-N 0.000 claims description 2
- OTHGIYKNMRJSJY-UHFFFAOYSA-N 3-[2-[4-[(2,5-dimethoxyphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound COC1=CC=C(OC)C(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=C1 OTHGIYKNMRJSJY-UHFFFAOYSA-N 0.000 claims description 2
- XZEKUBLAFYUEAY-UHFFFAOYSA-N 3-[2-[4-[(2-bromophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC=C1Br XZEKUBLAFYUEAY-UHFFFAOYSA-N 0.000 claims description 2
- COEVKEIWWBCNCS-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-fluorophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=C(F)C=CC=C1Cl COEVKEIWWBCNCS-UHFFFAOYSA-N 0.000 claims description 2
- RGKSMQJAFQAECO-UHFFFAOYSA-N 3-[2-[4-[(2-chlorophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC=C1Cl RGKSMQJAFQAECO-UHFFFAOYSA-N 0.000 claims description 2
- DWQNMQTXMFFXFS-UHFFFAOYSA-N 3-[2-[4-[(2-iodophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC=C1I DWQNMQTXMFFXFS-UHFFFAOYSA-N 0.000 claims description 2
- ANZNSWYTCCTIAA-UHFFFAOYSA-N 3-[2-[4-[(3,4-dimethoxyphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C1=C(OC)C(OC)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 ANZNSWYTCCTIAA-UHFFFAOYSA-N 0.000 claims description 2
- ROCFXWUPGGHLON-UHFFFAOYSA-N 3-[2-[4-[(3,5-dimethoxyphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound COC1=CC(OC)=CC(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=C1 ROCFXWUPGGHLON-UHFFFAOYSA-N 0.000 claims description 2
- ZJPPEPVWNRQKNW-UHFFFAOYSA-N 3-[2-[4-[(3,5-dimethylphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC(C)=CC(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=C1 ZJPPEPVWNRQKNW-UHFFFAOYSA-N 0.000 claims description 2
- OKPVDNZPPRLADN-UHFFFAOYSA-N 3-[2-[4-[(3-bromophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC(Br)=C1 OKPVDNZPPRLADN-UHFFFAOYSA-N 0.000 claims description 2
- PMHDKPAFENOANH-UHFFFAOYSA-N 3-[2-[4-[(3-chlorophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC(Cl)=C1 PMHDKPAFENOANH-UHFFFAOYSA-N 0.000 claims description 2
- QUTIYVVWYLXFLV-UHFFFAOYSA-N 3-[2-[4-[(3-fluorophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=CC(F)=C1 QUTIYVVWYLXFLV-UHFFFAOYSA-N 0.000 claims description 2
- FKHQVIIADAOZRQ-UHFFFAOYSA-N 3-[2-[4-[(4-bromophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=C(Br)C=C1 FKHQVIIADAOZRQ-UHFFFAOYSA-N 0.000 claims description 2
- NKSCVQFJMLBFQX-UHFFFAOYSA-N 3-[2-[4-[(4-butoxyphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCC)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 NKSCVQFJMLBFQX-UHFFFAOYSA-N 0.000 claims description 2
- NVBNPBMKWXDJRT-UHFFFAOYSA-N 3-[2-[4-[(4-chlorophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=C(Cl)C=C1 NVBNPBMKWXDJRT-UHFFFAOYSA-N 0.000 claims description 2
- UFKABGFVZVLARD-UHFFFAOYSA-N 3-[2-[4-[(4-fluorophenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(C2OCCN(CCC(O)=O)C2)C(C)=CC=1OCC1=CC=C(F)C=C1 UFKABGFVZVLARD-UHFFFAOYSA-N 0.000 claims description 2
- NJYFSVIXHTUMIA-UHFFFAOYSA-N 3-[2-[4-[[3-(dimethylamino)phenyl]methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound CN(C)C1=CC=CC(COC=2C=C(C)C(C3OCCN(CCC(O)=O)C3)=CC=2)=C1 NJYFSVIXHTUMIA-UHFFFAOYSA-N 0.000 claims description 2
- NFJOQNVMCFAQSB-UHFFFAOYSA-N 4-[2-(4-hexoxyphenyl)morpholin-4-yl]butanoic acid Chemical compound C1=CC(OCCCCCC)=CC=C1C1OCCN(CCCC(O)=O)C1 NFJOQNVMCFAQSB-UHFFFAOYSA-N 0.000 claims description 2
- XRGKZDOFTJXOTF-UHFFFAOYSA-N 4-[2-(4-octoxyphenyl)morpholin-4-yl]butanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCCC(O)=O)C1 XRGKZDOFTJXOTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 125000004188 dichlorophenyl group Chemical group 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- JQGHFTNVHMMFHW-UHFFFAOYSA-N 3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCC(O)=O)C1 JQGHFTNVHMMFHW-UHFFFAOYSA-N 0.000 claims 3
- 206010012289 Dementia Diseases 0.000 claims 2
- GCLYGYNLYMREGF-UHFFFAOYSA-N 2,2-dimethyl-3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CC(C)(C)C(O)=O)C1 GCLYGYNLYMREGF-UHFFFAOYSA-N 0.000 claims 1
- ZVZPFTCEXIGSHM-UHFFFAOYSA-N 2-fluoropropanoic acid Chemical compound CC(F)C(O)=O ZVZPFTCEXIGSHM-UHFFFAOYSA-N 0.000 claims 1
- IDROHSJFPQLVOW-UHFFFAOYSA-N 2-methyl-3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CC(C)C(O)=O)C1 IDROHSJFPQLVOW-UHFFFAOYSA-N 0.000 claims 1
- PBEGUGGKKSWIAN-UHFFFAOYSA-N 3-[2,2-dimethyl-6-(4-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OC(C)(C)CN(CCC(O)=O)C1 PBEGUGGKKSWIAN-UHFFFAOYSA-N 0.000 claims 1
- SQGYLRNWKBXHPK-UHFFFAOYSA-N 3-[2-(3-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound CCCCCCCCOC1=CC=CC(C2OCCN(CCC(O)=O)C2)=C1 SQGYLRNWKBXHPK-UHFFFAOYSA-N 0.000 claims 1
- KYVPDRVDNBEWIY-UHFFFAOYSA-N 3-[2-(3-phenylmethoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C1=CC=CC(OCC=2C=CC=CC=2)=C1 KYVPDRVDNBEWIY-UHFFFAOYSA-N 0.000 claims 1
- SRMZSHHHXAIAJI-UHFFFAOYSA-N 3-[2-(4-hexoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCC)=CC=C1C1OCCN(CCC(O)=O)C1 SRMZSHHHXAIAJI-UHFFFAOYSA-N 0.000 claims 1
- NSPXEHUZBFNYEV-UHFFFAOYSA-N 3-[2-(4-octoxyphenyl)-5-oxomorpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCC(=O)N(CCC(O)=O)C1 NSPXEHUZBFNYEV-UHFFFAOYSA-N 0.000 claims 1
- IDDWZTQPYFMFAF-UHFFFAOYSA-N 3-[2-(4-phenacylphenyl)morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1CC(=O)C1=CC=CC=C1 IDDWZTQPYFMFAF-UHFFFAOYSA-N 0.000 claims 1
- ONZGWDFDPAANCM-UHFFFAOYSA-N 3-[2-[2-(trifluoromethyl)-4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)C(F)(F)F)=CC=C1OCC1=CC=CC(C(F)(F)F)=C1 ONZGWDFDPAANCM-UHFFFAOYSA-N 0.000 claims 1
- RRTHYJCTHTWVNT-UHFFFAOYSA-N 3-[2-[2-fluoro-4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)F)=CC=C1OCC1=CC=CC=C1C(F)(F)F RRTHYJCTHTWVNT-UHFFFAOYSA-N 0.000 claims 1
- HLZSRDREPDNSCW-UHFFFAOYSA-N 3-[2-[3-[(2-chlorophenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C1=CC=CC(OCC=2C(=CC=CC=2)Cl)=C1 HLZSRDREPDNSCW-UHFFFAOYSA-N 0.000 claims 1
- QDYCZPMRBRQYRJ-UHFFFAOYSA-N 3-[2-[3-chloro-4-[(2-chloro-6-fluorophenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1Cl)=CC=C1OCC1=C(F)C=CC=C1Cl QDYCZPMRBRQYRJ-UHFFFAOYSA-N 0.000 claims 1
- SUEKANSDNYUTIP-UHFFFAOYSA-N 3-[2-[3-chloro-4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1Cl)=CC=C1OCC1=CC=CC=C1C(F)(F)F SUEKANSDNYUTIP-UHFFFAOYSA-N 0.000 claims 1
- TYJKQNKRXNXCRT-UHFFFAOYSA-N 3-[2-[3-methyl-4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC(C2OCCN(CCC(O)=O)C2)=CC=C1OCC1=CC=CC=C1C(F)(F)F TYJKQNKRXNXCRT-UHFFFAOYSA-N 0.000 claims 1
- CZFIWZAPBBXGDD-UHFFFAOYSA-N 3-[2-[4-(4,4-dimethylcyclohexyl)oxyphenyl]morpholin-4-yl]propanoic acid Chemical compound C1CC(C)(C)CCC1OC1=CC=C(C2OCCN(CCC(O)=O)C2)C=C1 CZFIWZAPBBXGDD-UHFFFAOYSA-N 0.000 claims 1
- QNYIPLWCMJZSSQ-UHFFFAOYSA-N 3-[2-[4-(4-phenoxybutoxy)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCCCCOC1=CC=CC=C1 QNYIPLWCMJZSSQ-UHFFFAOYSA-N 0.000 claims 1
- NUDSEHJQWBQTNZ-UHFFFAOYSA-N 3-[2-[4-(4-phenylbutoxy)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCCCCC1=CC=CC=C1 NUDSEHJQWBQTNZ-UHFFFAOYSA-N 0.000 claims 1
- TZPADXSPNQSYQY-UHFFFAOYSA-N 3-[2-[4-(5-oxohexoxy)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCC(=O)C)=CC=C1C1OCCN(CCC(O)=O)C1 TZPADXSPNQSYQY-UHFFFAOYSA-N 0.000 claims 1
- PXFRSSNHRVPISY-UHFFFAOYSA-N 3-[2-[4-[(2,6-dimethylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=CC(C)=C1COC1=CC=C(C2OCCN(CCC(O)=O)C2)C=C1 PXFRSSNHRVPISY-UHFFFAOYSA-N 0.000 claims 1
- QDYUJOIWQRGXMP-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-3-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=CC(COC=2C=CC(=CC=2)C2OCCN(CCC(O)=O)C2)=C1Cl QDYUJOIWQRGXMP-UHFFFAOYSA-N 0.000 claims 1
- DAOBYERMFWTMNQ-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-4-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound ClC1=CC(C)=CC=C1COC1=CC=C(C2OCCN(CCC(O)=O)C2)C=C1 DAOBYERMFWTMNQ-UHFFFAOYSA-N 0.000 claims 1
- LLJBFBWXKPMCBI-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-5-ethylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CCC1=CC=C(Cl)C(COC=2C=CC(=CC=2)C2OCCN(CCC(O)=O)C2)=C1 LLJBFBWXKPMCBI-UHFFFAOYSA-N 0.000 claims 1
- MLVDZYUUADOAHN-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-5-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=C(Cl)C(COC=2C=CC(=CC=2)C2OCCN(CCC(O)=O)C2)=C1 MLVDZYUUADOAHN-UHFFFAOYSA-N 0.000 claims 1
- CVILWGYINYYMHB-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-cyclopropylphenyl)methoxy]-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)C(F)(F)F)=CC=C1OCC1=C(Cl)C=CC=C1C1CC1 CVILWGYINYYMHB-UHFFFAOYSA-N 0.000 claims 1
- UZMUEUFIKKRVJH-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-cyclopropylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=C(Cl)C=CC=C1C1CC1 UZMUEUFIKKRVJH-UHFFFAOYSA-N 0.000 claims 1
- HXQGIYVJWBNJMA-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-ethylphenyl)methoxy]-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoic acid Chemical compound CCC1=CC=CC(Cl)=C1COC(C=C1C(F)(F)F)=CC=C1C1OCCN(CCC(O)=O)C1 HXQGIYVJWBNJMA-UHFFFAOYSA-N 0.000 claims 1
- LQQRFIHRJKKQNP-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-ethylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CCC1=CC=CC(Cl)=C1COC1=CC=C(C2OCCN(CCC(O)=O)C2)C=C1 LQQRFIHRJKKQNP-UHFFFAOYSA-N 0.000 claims 1
- XMBKRSFSMDLZQR-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-fluorophenyl)methoxy]-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)C(F)(F)F)=CC=C1OCC1=C(F)C=CC=C1Cl XMBKRSFSMDLZQR-UHFFFAOYSA-N 0.000 claims 1
- FCHBIGDMBOZJKW-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-fluorophenyl)methoxy]-2-fluorophenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)F)=CC=C1OCC1=C(F)C=CC=C1Cl FCHBIGDMBOZJKW-UHFFFAOYSA-N 0.000 claims 1
- XXGLSLSFGRJWAC-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-fluorophenyl)methoxy]-3-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC(C2OCCN(CCC(O)=O)C2)=CC=C1OCC1=C(F)C=CC=C1Cl XXGLSLSFGRJWAC-UHFFFAOYSA-N 0.000 claims 1
- FZFUYEPRRVJZBU-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-fluorophenyl)methoxy]phenyl]-2-methylmorpholin-4-yl]propanoic acid Chemical compound C=1C=C(OCC=2C(=CC=CC=2F)Cl)C=CC=1C1(C)CN(CCC(O)=O)CCO1 FZFUYEPRRVJZBU-UHFFFAOYSA-N 0.000 claims 1
- YVJBYESXGBKOEW-UHFFFAOYSA-N 3-[2-[4-[(2-chloro-6-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC1=CC=CC(Cl)=C1COC1=CC=C(C2OCCN(CCC(O)=O)C2)C=C1 YVJBYESXGBKOEW-UHFFFAOYSA-N 0.000 claims 1
- QWCGUMBXBIBSLB-UHFFFAOYSA-N 3-[2-[4-[(2-chlorophenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=CC=C1Cl QWCGUMBXBIBSLB-UHFFFAOYSA-N 0.000 claims 1
- BZNOIUQXGYLFQW-UHFFFAOYSA-N 3-[2-[4-[(3-chlorophenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=CC(Cl)=C1 BZNOIUQXGYLFQW-UHFFFAOYSA-N 0.000 claims 1
- LASXNGYFZKHDEO-UHFFFAOYSA-N 3-[2-[4-[(4-butylphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid;3-[2-[2-methyl-4-[(4-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1=CC(C)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1.C1=CC(CCCC)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 LASXNGYFZKHDEO-UHFFFAOYSA-N 0.000 claims 1
- IRRJHYJULFYDJN-UHFFFAOYSA-N 3-[2-[4-[(4-chlorophenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=C(Cl)C=C1 IRRJHYJULFYDJN-UHFFFAOYSA-N 0.000 claims 1
- XERXDJJURGXQCL-UHFFFAOYSA-N 3-[2-[4-[(4-pyrazol-1-ylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=C(N2N=CC=C2)C=C1 XERXDJJURGXQCL-UHFFFAOYSA-N 0.000 claims 1
- FJWKPTSJRYBIJD-UHFFFAOYSA-N 3-[2-[4-[(6-methylimidazo[1,2-a]pyridin-2-yl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1N2C=C(C)C=CC2=NC=1COC(C=C1)=CC=C1C1CN(CCC(O)=O)CCO1 FJWKPTSJRYBIJD-UHFFFAOYSA-N 0.000 claims 1
- WAWRRFHQCYDUFW-UHFFFAOYSA-N 3-[2-[4-[[2,6-dichloro-4-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=C(Cl)C=C(C(F)(F)F)C=C1Cl WAWRRFHQCYDUFW-UHFFFAOYSA-N 0.000 claims 1
- YZOFNMVZJXBAIF-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-3-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=CC(C(F)(F)F)=C1Cl YZOFNMVZJXBAIF-UHFFFAOYSA-N 0.000 claims 1
- YOSZGSHRIYGACR-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-5-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC(C(F)(F)F)=CC=C1Cl YOSZGSHRIYGACR-UHFFFAOYSA-N 0.000 claims 1
- BSOIGSPINNEOFR-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-6-(2-methylpropyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound CC(C)CC1=CC=CC(Cl)=C1COC1=CC=C(C2OCCN(CCC(O)=O)C2)C=C1 BSOIGSPINNEOFR-UHFFFAOYSA-N 0.000 claims 1
- ZXERLGFDBUXFDS-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-6-(trifluoromethoxy)phenyl]methoxy]-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)C(F)(F)F)=CC=C1OCC1=C(Cl)C=CC=C1OC(F)(F)F ZXERLGFDBUXFDS-UHFFFAOYSA-N 0.000 claims 1
- YYYSGUMRWQBXSA-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-6-(trifluoromethoxy)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=C(Cl)C=CC=C1OC(F)(F)F YYYSGUMRWQBXSA-UHFFFAOYSA-N 0.000 claims 1
- YOQMLWYUDAWBBK-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-6-(trifluoromethyl)phenyl]methoxy]-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C(=C1)C(F)(F)F)=CC=C1OCC1=C(Cl)C=CC=C1C(F)(F)F YOQMLWYUDAWBBK-UHFFFAOYSA-N 0.000 claims 1
- LCPIEKYKOWPARX-UHFFFAOYSA-N 3-[2-[4-[[2-chloro-6-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=C(Cl)C=CC=C1C(F)(F)F LCPIEKYKOWPARX-UHFFFAOYSA-N 0.000 claims 1
- IBPSOBMPKCXHKW-UHFFFAOYSA-N 3-[2-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=CC(C(F)(F)F)=C1 IBPSOBMPKCXHKW-UHFFFAOYSA-N 0.000 claims 1
- JYIRYZLMURFIMD-UHFFFAOYSA-N 3-[2-[4-[[4-(1,2,4-triazol-1-yl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1N(CCC(=O)O)CCOC1C(C=C1)=CC=C1OCC1=CC=C(N2N=CN=C2)C=C1 JYIRYZLMURFIMD-UHFFFAOYSA-N 0.000 claims 1
- VUADGDHGWUDIFY-UHFFFAOYSA-N 3-[2-[4-octoxy-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoic acid Chemical compound FC(F)(F)C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCC(O)=O)C1 VUADGDHGWUDIFY-UHFFFAOYSA-N 0.000 claims 1
- FVHVEXBGZVMWPS-UHFFFAOYSA-N 3-[2-methyl-2-(4-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1(C)OCCN(CCC(O)=O)C1 FVHVEXBGZVMWPS-UHFFFAOYSA-N 0.000 claims 1
- IFRNFBCBOHGFKH-UHFFFAOYSA-N 3-[2-methyl-2-[4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C=1C=C(OCC=2C(=CC=CC=2)C(F)(F)F)C=CC=1C1(C)CN(CCC(O)=O)CCO1 IFRNFBCBOHGFKH-UHFFFAOYSA-N 0.000 claims 1
- CENWDRNLSWCUKA-UHFFFAOYSA-N 3-[5,5-dimethyl-2-(4-octoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCC(C)(C)N(CCC(O)=O)C1 CENWDRNLSWCUKA-UHFFFAOYSA-N 0.000 claims 1
- MUIUNOUPBNGQFM-UHFFFAOYSA-N 3-[5-oxo-2-(4-phenylmethoxyphenyl)morpholin-4-yl]propanoic acid Chemical compound O1CC(=O)N(CCC(=O)O)CC1C(C=C1)=CC=C1OCC1=CC=CC=C1 MUIUNOUPBNGQFM-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 13
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical class C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract description 11
- 102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 abstract description 4
- 108050001083 Sphingosine 1-phosphate receptors Proteins 0.000 abstract description 4
- 125000001424 substituent group Chemical group 0.000 abstract description 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 229910018828 PO3H2 Inorganic materials 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 271
- 239000000203 mixture Substances 0.000 description 243
- JAELLLITIZHOGQ-UHFFFAOYSA-N tert-butyl propanoate Chemical compound CCC(=O)OC(C)(C)C JAELLLITIZHOGQ-UHFFFAOYSA-N 0.000 description 195
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 142
- 239000000243 solution Substances 0.000 description 126
- 239000012141 concentrate Substances 0.000 description 112
- 239000007864 aqueous solution Substances 0.000 description 96
- 239000012044 organic layer Substances 0.000 description 87
- 239000002904 solvent Substances 0.000 description 76
- 238000004440 column chromatography Methods 0.000 description 73
- 239000011734 sodium Substances 0.000 description 73
- 235000019439 ethyl acetate Nutrition 0.000 description 71
- 229910004298 SiO 2 Inorganic materials 0.000 description 70
- 238000005481 NMR spectroscopy Methods 0.000 description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 60
- 239000002585 base Substances 0.000 description 56
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical group CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 55
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 51
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 50
- 238000003756 stirring Methods 0.000 description 50
- 239000011541 reaction mixture Substances 0.000 description 46
- 239000010410 layer Substances 0.000 description 44
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 41
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 37
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 36
- 238000005259 measurement Methods 0.000 description 34
- 238000006243 chemical reaction Methods 0.000 description 33
- 238000005160 1H NMR spectroscopy Methods 0.000 description 32
- DYWOPZYICSJYMT-UHFFFAOYSA-N propanoic acid;2,2,2-trifluoroacetic acid Chemical compound CCC(O)=O.OC(=O)C(F)(F)F DYWOPZYICSJYMT-UHFFFAOYSA-N 0.000 description 32
- 238000010992 reflux Methods 0.000 description 28
- 238000000034 method Methods 0.000 description 27
- 239000003513 alkali Substances 0.000 description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 20
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 20
- 238000005406 washing Methods 0.000 description 20
- DUYSYHSSBDVJSM-KRWOKUGFSA-N sphingosine 1-phosphate Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(O)=O DUYSYHSSBDVJSM-KRWOKUGFSA-N 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- ITTACMGCVMCVBK-UHFFFAOYSA-N 2-(4-octoxyphenyl)morpholine Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCNC1 ITTACMGCVMCVBK-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 14
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 14
- 150000001335 aliphatic alkanes Chemical class 0.000 description 14
- 238000010438 heat treatment Methods 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 229910052799 carbon Inorganic materials 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 239000012267 brine Substances 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 11
- 102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 description 10
- NSYVLERQTZQOKU-UHFFFAOYSA-N 4-benzyl-2-(4-bromophenyl)morpholine Chemical compound C1=CC(Br)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 NSYVLERQTZQOKU-UHFFFAOYSA-N 0.000 description 9
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 9
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- 101710155454 Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 8
- 102100025747 Sphingosine 1-phosphate receptor 3 Human genes 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 108010041089 apoaequorin Proteins 0.000 description 8
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 8
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 8
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 7
- 101710155457 Sphingosine 1-phosphate receptor 3 Proteins 0.000 description 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000007872 degassing Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 7
- PIMNFNXBTGPCIL-UHFFFAOYSA-N 1-(2-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1Br PIMNFNXBTGPCIL-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000002168 alkylating agent Substances 0.000 description 6
- 229940100198 alkylating agent Drugs 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 235000015320 potassium carbonate Nutrition 0.000 description 6
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 6
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 150000001414 amino alcohols Chemical class 0.000 description 5
- 229910000085 borane Inorganic materials 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001590 oxidative effect Effects 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- QPFKBFNEZOZWHB-UHFFFAOYSA-N tert-butyl 3-[2-(4-hydroxyphenyl)morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=C(O)C=C1 QPFKBFNEZOZWHB-UHFFFAOYSA-N 0.000 description 5
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidine Chemical compound CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 description 4
- SPYKWWHNOUIGKX-UHFFFAOYSA-N 2-(benzylamino)-1-(4-octoxyphenyl)ethanol Chemical compound C1=CC(OCCCCCCCC)=CC=C1C(O)CNCC1=CC=CC=C1 SPYKWWHNOUIGKX-UHFFFAOYSA-N 0.000 description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical class CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- YRPUJOJAHFKBPB-UHFFFAOYSA-N 4-(4-benzylmorpholin-2-yl)aniline Chemical compound C1=CC(N)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 YRPUJOJAHFKBPB-UHFFFAOYSA-N 0.000 description 4
- GVWBJJLCTWNTRU-UHFFFAOYSA-N 4-benzylmorpholine Chemical compound C=1C=CC=CC=1CN1CCOCC1 GVWBJJLCTWNTRU-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 4
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 4
- 230000008484 agonism Effects 0.000 description 4
- 235000019445 benzyl alcohol Nutrition 0.000 description 4
- 229960004217 benzyl alcohol Drugs 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 4
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 4
- LCEDQNDDFOCWGG-UHFFFAOYSA-N morpholine-4-carbaldehyde Chemical compound O=CN1CCOCC1 LCEDQNDDFOCWGG-UHFFFAOYSA-N 0.000 description 4
- BYHWOMFXNSFARS-UHFFFAOYSA-N n-[4-(4-benzylmorpholin-2-yl)phenyl]-1,1-diphenylmethanimine Chemical compound C=1C=CC=CC=1CN(C1)CCOC1C(C=C1)=CC=C1N=C(C=1C=CC=CC=1)C1=CC=CC=C1 BYHWOMFXNSFARS-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 4
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 4
- IPSRAFUHLHIWAR-UHFFFAOYSA-N zinc;ethane Chemical group [Zn+2].[CH2-]C.[CH2-]C IPSRAFUHLHIWAR-UHFFFAOYSA-N 0.000 description 4
- NGLFEEFBKRFPCQ-UHFFFAOYSA-N 1-amino-2-(4-phenylmethoxyphenyl)propan-2-ol Chemical compound C1=CC(C(O)(CN)C)=CC=C1OCC1=CC=CC=C1 NGLFEEFBKRFPCQ-UHFFFAOYSA-N 0.000 description 3
- QSSXJPIWXQTSIX-UHFFFAOYSA-N 1-bromo-2-methylbenzene Chemical compound CC1=CC=CC=C1Br QSSXJPIWXQTSIX-UHFFFAOYSA-N 0.000 description 3
- YZOUUVUNKGUDSK-UHFFFAOYSA-N 2-amino-1-(4-phenylmethoxyphenyl)ethanol Chemical compound C1=CC(C(O)CN)=CC=C1OCC1=CC=CC=C1 YZOUUVUNKGUDSK-UHFFFAOYSA-N 0.000 description 3
- WAKFRZBXTKUFIW-UHFFFAOYSA-N 2-bromo-2-phenylacetic acid Chemical class OC(=O)C(Br)C1=CC=CC=C1 WAKFRZBXTKUFIW-UHFFFAOYSA-N 0.000 description 3
- WHQWDDQHTCHIOX-UHFFFAOYSA-N 2-chloro-n-[2-hydroxy-2-(4-phenylmethoxyphenyl)ethyl]acetamide Chemical compound C1=CC(C(CNC(=O)CCl)O)=CC=C1OCC1=CC=CC=C1 WHQWDDQHTCHIOX-UHFFFAOYSA-N 0.000 description 3
- NPOGEQBCDDJZEF-UHFFFAOYSA-N 4-(4-benzylmorpholin-2-yl)-2-chlorophenol Chemical compound C1=C(Cl)C(O)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 NPOGEQBCDDJZEF-UHFFFAOYSA-N 0.000 description 3
- JELLJOYLAHXFRL-UHFFFAOYSA-N 4-(4-benzylmorpholin-2-yl)-3-chlorophenol Chemical compound ClC1=CC(O)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 JELLJOYLAHXFRL-UHFFFAOYSA-N 0.000 description 3
- LRUCQBKKWMIXSH-UHFFFAOYSA-N 4-(4-benzylmorpholin-2-yl)phenol Chemical compound C1=CC(O)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 LRUCQBKKWMIXSH-UHFFFAOYSA-N 0.000 description 3
- DDVQGTVARPCRGV-UHFFFAOYSA-N 4-benzyl-2-(4-octoxyphenyl)morpholine Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 DDVQGTVARPCRGV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- WOPCTMKWJVMSJB-UHFFFAOYSA-N C1=CC=C(C=C1)COC2=CC=C(C=C2)C(CN=[N+]=[N-])C(=O)C(CN=[N+]=[N-])C3=CC=C(C=C3)OCC4=CC=CC=C4 Chemical compound C1=CC=C(C=C1)COC2=CC=C(C=C2)C(CN=[N+]=[N-])C(=O)C(CN=[N+]=[N-])C3=CC=C(C=C3)OCC4=CC=CC=C4 WOPCTMKWJVMSJB-UHFFFAOYSA-N 0.000 description 3
- DLCLPCOSDVXGJC-UHFFFAOYSA-N CC(C1=C(C=C(C=C1)OCC2=CC=CC=C2)CN)C(=O)C(C)C3=C(C=C(C=C3)OCC4=CC=CC=C4)CN Chemical compound CC(C1=C(C=C(C=C1)OCC2=CC=CC=C2)CN)C(=O)C(C)C3=C(C=C(C=C3)OCC4=CC=CC=C4)CN DLCLPCOSDVXGJC-UHFFFAOYSA-N 0.000 description 3
- FYFNEBYHGVMRIP-UHFFFAOYSA-N CC(C1=CC(=C(C=C1)OCC2=CC=CC=C2)C(F)(F)F)C(=O)C(C)C3=CC(=C(C=C3)OCC4=CC=CC=C4)C(F)(F)F Chemical compound CC(C1=CC(=C(C=C1)OCC2=CC=CC=C2)C(F)(F)F)C(=O)C(C)C3=CC(=C(C=C3)OCC4=CC=CC=C4)C(F)(F)F FYFNEBYHGVMRIP-UHFFFAOYSA-N 0.000 description 3
- YZFCDIRODCNFGW-UHFFFAOYSA-N CCCCCCCCOC1=CC=C(C=C1)C(C)C(=O)C(C)C2=CC=C(C=C2)OCCCCCCCC Chemical compound CCCCCCCCOC1=CC=C(C=C1)C(C)C(=O)C(C)C2=CC=C(C=C2)OCCCCCCCC YZFCDIRODCNFGW-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229910010082 LiAlH Inorganic materials 0.000 description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- RKSIAYQZVYZOSM-UHFFFAOYSA-N ethyl 2-fluoro-3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C(C)OC(C(CN1CC(OCC1)C1=CC=C(C=C1)OCCCCCCCC)F)=O RKSIAYQZVYZOSM-UHFFFAOYSA-N 0.000 description 3
- QTUBRUYMZAIKNU-UHFFFAOYSA-N ethyl 3-[2-(4-octoxyphenyl)morpholin-4-yl]-3-oxopropanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(C(=O)CC(=O)OCC)C1 QTUBRUYMZAIKNU-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 3
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 3
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 3
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- LTKJEADLVPVVGL-UHFFFAOYSA-N tert-butyl 2-methyl-3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CC(C)C(=O)OC(C)(C)C)C1 LTKJEADLVPVVGL-UHFFFAOYSA-N 0.000 description 3
- HCXZHDAFIVPSOQ-UHFFFAOYSA-N tert-butyl 3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCC(=O)OC(C)(C)C)C1 HCXZHDAFIVPSOQ-UHFFFAOYSA-N 0.000 description 3
- MDXXFSFEDSOBIA-UHFFFAOYSA-N tert-butyl 3-[5-oxo-2-(4-phenylmethoxyphenyl)morpholin-4-yl]propanoate Chemical compound O1CC(=O)N(CCC(=O)OC(C)(C)C)CC1C(C=C1)=CC=C1OCC1=CC=CC=C1 MDXXFSFEDSOBIA-UHFFFAOYSA-N 0.000 description 3
- BMTKZHSFDITAAC-UHFFFAOYSA-N tert-butyl 3-bromobutanoate Chemical compound CC(Br)CC(=O)OC(C)(C)C BMTKZHSFDITAAC-UHFFFAOYSA-N 0.000 description 3
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 3
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 3
- XXSLZJZUSYNITM-UHFFFAOYSA-N tetrabutylammonium tribromide Chemical compound Br[Br-]Br.CCCC[N+](CCCC)(CCCC)CCCC XXSLZJZUSYNITM-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- ISXZODKJGHQFRD-UHFFFAOYSA-N 1-(benzylamino)-2-(4-phenylmethoxyphenyl)propan-2-ol Chemical compound C=1C=C(OCC=2C=CC=CC=2)C=CC=1C(O)(C)CNCC1=CC=CC=C1 ISXZODKJGHQFRD-UHFFFAOYSA-N 0.000 description 2
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 2
- CVGAWKYSRYXQOI-UHFFFAOYSA-N 1-chloro-2-ethylbenzene Chemical class CCC1=CC=CC=C1Cl CVGAWKYSRYXQOI-UHFFFAOYSA-N 0.000 description 2
- OSOUNOBYRMOXQQ-UHFFFAOYSA-N 1-chloro-3-methylbenzene Chemical compound CC1=CC=CC(Cl)=C1 OSOUNOBYRMOXQQ-UHFFFAOYSA-N 0.000 description 2
- GPOFSFLJOIAMSA-UHFFFAOYSA-N 1-chloro-4-ethylbenzene Chemical compound CCC1=CC=C(Cl)C=C1 GPOFSFLJOIAMSA-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- JBLIDPPHFGWTKU-UHFFFAOYSA-N 2,6-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=C(Cl)C=CC=C1Cl JBLIDPPHFGWTKU-UHFFFAOYSA-N 0.000 description 2
- PDFGFQUSSYSWNI-UHFFFAOYSA-N 2-(bromomethyl)-1,3-dichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1CBr PDFGFQUSSYSWNI-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- OWQUYBAASOSGNO-CDNKMLFNSA-N 2-[[(Z)-N-(2-hydroxy-5-sulfoanilino)-C-phenylcarbonimidoyl]diazenyl]benzoic acid Chemical compound C1=CC=C(C=C1)/C(=N/NC2=C(C=CC(=C2)S(=O)(=O)O)O)/N=NC3=CC=CC=C3C(=O)O OWQUYBAASOSGNO-CDNKMLFNSA-N 0.000 description 2
- XNMQEEKYCVKGBD-UHFFFAOYSA-N 2-butyne Chemical compound CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 2
- DTIJZEUKFYGSEC-UHFFFAOYSA-N 2-chloro-4-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(C(F)(F)F)C=C1Cl DTIJZEUKFYGSEC-UHFFFAOYSA-N 0.000 description 2
- MYJUBDJLKREUGU-UHFFFAOYSA-N 2-chloro-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(Cl)=C1 MYJUBDJLKREUGU-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- NZXKNZOKGCOJDO-UHFFFAOYSA-N 4-(4-benzylmorpholin-2-yl)-3-(trifluoromethyl)phenol Chemical compound FC(F)(F)C1=CC(O)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 NZXKNZOKGCOJDO-UHFFFAOYSA-N 0.000 description 2
- XHOCUIXNTNWZEY-UHFFFAOYSA-N 4-(4-octoxyphenyl)morpholine Chemical compound C1=CC(OCCCCCCCC)=CC=C1N1CCOCC1 XHOCUIXNTNWZEY-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- QIWJKNVVVFWUFY-UHFFFAOYSA-N 4-benzyl-2-(4-hexoxyphenyl)morpholine Chemical compound C1=CC(OCCCCCC)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 QIWJKNVVVFWUFY-UHFFFAOYSA-N 0.000 description 2
- AAAKCCGJBOCMOF-UHFFFAOYSA-N 4-benzyl-5,5-dimethyl-2-(4-phenylmethoxyphenyl)morpholine Chemical compound CC1(C)COC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)CN1CC1=CC=CC=C1 AAAKCCGJBOCMOF-UHFFFAOYSA-N 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 2
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonane Substances C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 2
- 108010000239 Aequorin Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 2
- BZVASRBRFHPVJD-UHFFFAOYSA-N C=O.ClC1=CC(=CC=C1)CC Chemical compound C=O.ClC1=CC(=CC=C1)CC BZVASRBRFHPVJD-UHFFFAOYSA-N 0.000 description 2
- MPBJAIALWSLLOP-UHFFFAOYSA-N CC(C1=CC(=C(C=C1)OCC2=CC=CC=C2)CN)C(=O)C(C)C3=CC(=C(C=C3)OCC4=CC=CC=C4)CN Chemical compound CC(C1=CC(=C(C=C1)OCC2=CC=CC=C2)CN)C(=O)C(C)C3=CC(=C(C=C3)OCC4=CC=CC=C4)CN MPBJAIALWSLLOP-UHFFFAOYSA-N 0.000 description 2
- ITXRGAUGAJPMBM-UHFFFAOYSA-N CCNC1=CC=C(Cl)C(C#N)=C1 Chemical compound CCNC1=CC=C(Cl)C(C#N)=C1 ITXRGAUGAJPMBM-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 238000006845 Michael addition reaction Methods 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 238000010934 O-alkylation reaction Methods 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 102100025749 Sphingosine 1-phosphate receptor 2 Human genes 0.000 description 2
- 101710155462 Sphingosine 1-phosphate receptor 2 Proteins 0.000 description 2
- 102100029803 Sphingosine 1-phosphate receptor 4 Human genes 0.000 description 2
- 101710155458 Sphingosine 1-phosphate receptor 4 Proteins 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- GAECKXKPNULUAG-UHFFFAOYSA-N [4-(2-bromoacetyl)-3-(trifluoromethyl)phenyl] methanesulfonate Chemical compound CS(=O)(=O)OC1=CC=C(C(=O)CBr)C(C(F)(F)F)=C1 GAECKXKPNULUAG-UHFFFAOYSA-N 0.000 description 2
- QAOFXQAJXMZFDT-UHFFFAOYSA-N [4-[2-(benzylamino)-1-hydroxyethyl]-3-(trifluoromethyl)phenyl] methanesulfonate Chemical compound FC(F)(F)C1=CC(OS(=O)(=O)C)=CC=C1C(O)CNCC1=CC=CC=C1 QAOFXQAJXMZFDT-UHFFFAOYSA-N 0.000 description 2
- BBJIDSHZKDGAFG-UHFFFAOYSA-N [4-acetyl-3-(trifluoromethyl)phenyl] methanesulfonate Chemical compound CC(=O)C1=CC=C(OS(C)(=O)=O)C=C1C(F)(F)F BBJIDSHZKDGAFG-UHFFFAOYSA-N 0.000 description 2
- BVXLLZBMCZWPGZ-UHFFFAOYSA-N [SiH4].[Br-].C[NH+](C)C Chemical compound [SiH4].[Br-].C[NH+](C)C BVXLLZBMCZWPGZ-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001347 alkyl bromides Chemical class 0.000 description 2
- 150000001348 alkyl chlorides Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminum chloride Substances Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- KDKYADYSIPSCCQ-UHFFFAOYSA-N but-1-yne Chemical group CCC#C KDKYADYSIPSCCQ-UHFFFAOYSA-N 0.000 description 2
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- TXWOGHSRPAYOML-UHFFFAOYSA-N cyclobutanecarboxylic acid Chemical compound OC(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-N 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- LXCYSACZTOKNNS-UHFFFAOYSA-N diethoxy(oxo)phosphanium Chemical compound CCO[P+](=O)OCC LXCYSACZTOKNNS-UHFFFAOYSA-N 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 2
- PMIMPBYTPPRBGD-UHFFFAOYSA-N ethyl 2-chloropyridine-3-carboxylate Chemical class CCOC(=O)C1=CC=CN=C1Cl PMIMPBYTPPRBGD-UHFFFAOYSA-N 0.000 description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 229940058172 ethylbenzene Drugs 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 125000005956 isoquinolyl group Chemical group 0.000 description 2
- 230000000155 isotopic effect Effects 0.000 description 2
- XFKYUMYFILZJGG-UHFFFAOYSA-N methyl 2,2-dimethyl-3-oxopropanoate Chemical compound COC(=O)C(C)(C)C=O XFKYUMYFILZJGG-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 150000002780 morpholines Chemical class 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000004248 oligodendroglia Anatomy 0.000 description 2
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 2
- 235000007715 potassium iodide Nutrition 0.000 description 2
- 229960004839 potassium iodide Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Substances [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- SGWLBEYIPGVNCV-UHFFFAOYSA-N tert-butyl 2-(4-hydroxyphenyl)morpholine-4-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCOC1C1=CC=C(O)C=C1 SGWLBEYIPGVNCV-UHFFFAOYSA-N 0.000 description 2
- ZPOUPMBCVQFCJJ-UHFFFAOYSA-N tert-butyl 3-[2-(4-hydroxy-2-methylphenyl)morpholin-4-yl]propanoate Chemical compound CC1=CC(O)=CC=C1C1OCCN(CCC(=O)OC(C)(C)C)C1 ZPOUPMBCVQFCJJ-UHFFFAOYSA-N 0.000 description 2
- BWTHVVVMGJRHRB-UHFFFAOYSA-N tert-butyl 3-[2-(4-octoxyphenyl)morpholin-4-yl]butanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(C(C)CC(=O)OC(C)(C)C)C1 BWTHVVVMGJRHRB-UHFFFAOYSA-N 0.000 description 2
- NORXLPQHSFZGJN-UHFFFAOYSA-N tert-butyl 3-[2-[4-[(2,6-dimethylphenyl)methoxy]phenyl]morpholin-4-yl]propanoate Chemical compound CC1=CC=CC(C)=C1COC1=CC=C(C2OCCN(CCC(=O)OC(C)(C)C)C2)C=C1 NORXLPQHSFZGJN-UHFFFAOYSA-N 0.000 description 2
- LINGRBRGPISJGX-UHFFFAOYSA-N tert-butyl 4-[2-(4-octoxyphenyl)morpholin-4-yl]butanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCCC(=O)OC(C)(C)C)C1 LINGRBRGPISJGX-UHFFFAOYSA-N 0.000 description 2
- TWBUVVYSQBFVGZ-UHFFFAOYSA-N tert-butyl butanoate Chemical compound CCCC(=O)OC(C)(C)C TWBUVVYSQBFVGZ-UHFFFAOYSA-N 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 150000007970 thio esters Chemical class 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- 230000003936 working memory Effects 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- 229940043798 zincon Drugs 0.000 description 2
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- JPEYJQDKTDVJSZ-UHFFFAOYSA-N (2,6-dimethylphenyl)methanol Chemical compound CC1=CC=CC(C)=C1CO JPEYJQDKTDVJSZ-UHFFFAOYSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- HGJVENHHPPQQKV-UHFFFAOYSA-N (4-acetyl-2-chlorophenyl) methanesulfonate Chemical compound CC(=O)C1=CC=C(OS(C)(=O)=O)C(Cl)=C1 HGJVENHHPPQQKV-UHFFFAOYSA-N 0.000 description 1
- GWYMPJCKSRRSGA-UHFFFAOYSA-N (4-acetyl-3-fluorophenyl) methanesulfonate Chemical compound CC(=O)C1=CC=C(OS(C)(=O)=O)C=C1F GWYMPJCKSRRSGA-UHFFFAOYSA-N 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 1
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 description 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N 1,1'-Carbonyldiimidazole Substances C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- YJCVRMIJBXTMNR-UHFFFAOYSA-N 1,3-dichloro-2-ethenylbenzene Chemical compound ClC1=CC=CC(Cl)=C1C=C YJCVRMIJBXTMNR-UHFFFAOYSA-N 0.000 description 1
- HMVKMAMIRAVXAN-UHFFFAOYSA-N 1,3-dichloro-2-isocyanatobenzene Chemical compound ClC1=CC=CC(Cl)=C1N=C=O HMVKMAMIRAVXAN-UHFFFAOYSA-N 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- XMCRWEBERCXJCH-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)C=C1Cl XMCRWEBERCXJCH-UHFFFAOYSA-N 0.000 description 1
- GEUAWNMVARSYHO-UHFFFAOYSA-N 1-(6-hydroxy-4,7-dimethoxy-1-benzofuran-5-yl)ethanone Chemical compound COC1=C(O)C(C(C)=O)=C(OC)C2=C1OC=C2 GEUAWNMVARSYHO-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 description 1
- DZHFFMWJXJBBRG-UHFFFAOYSA-N 1-bromo-3,5-dichlorobenzene Chemical compound ClC1=CC(Cl)=CC(Br)=C1 DZHFFMWJXJBBRG-UHFFFAOYSA-N 0.000 description 1
- OLDJEKBXICPMAS-UHFFFAOYSA-N 1-chloro-3-(trifluoromethoxy)benzene Chemical compound FC(F)(F)OC1=CC=CC(Cl)=C1 OLDJEKBXICPMAS-UHFFFAOYSA-N 0.000 description 1
- YTCGOUNVIAWCMG-UHFFFAOYSA-N 1-chloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(Cl)=C1 YTCGOUNVIAWCMG-UHFFFAOYSA-N 0.000 description 1
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
- UBNPTJSGEYBDCQ-UHFFFAOYSA-N 1-phenylethanone Chemical class CC(=O)C1=CC=CC=C1.CC(=O)C1=CC=CC=C1 UBNPTJSGEYBDCQ-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- XVRIKYPDSOCUHO-UHFFFAOYSA-N 2,4-bis(4-phenylmethoxyphenyl)pentan-3-one Chemical compound C=1C=C(OCC=2C=CC=CC=2)C=CC=1C(C)C(=O)C(C)C(C=C1)=CC=C1OCC1=CC=CC=C1 XVRIKYPDSOCUHO-UHFFFAOYSA-N 0.000 description 1
- TYPVHTOETJVYIV-UHFFFAOYSA-N 2,4-dichloropyridine Chemical compound ClC1=CC=NC(Cl)=C1 TYPVHTOETJVYIV-UHFFFAOYSA-N 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- SOWRUJSGHKNOKN-UHFFFAOYSA-N 2,6-difluorobenzaldehyde Chemical compound FC1=CC=CC(F)=C1C=O SOWRUJSGHKNOKN-UHFFFAOYSA-N 0.000 description 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 1
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 1
- PKUVEGCXMITDDS-UHFFFAOYSA-N 2-(4-hexoxyphenyl)morpholine Chemical compound C1=CC(OCCCCCC)=CC=C1C1OCCNC1 PKUVEGCXMITDDS-UHFFFAOYSA-N 0.000 description 1
- HOZMUOMOJMPPFK-UHFFFAOYSA-N 2-(4-octoxyphenyl)morpholine;hydrochloride Chemical compound Cl.C1=CC(OCCCCCCCC)=CC=C1C1OCCNC1 HOZMUOMOJMPPFK-UHFFFAOYSA-N 0.000 description 1
- WYCSPSKHHDVQQA-UHFFFAOYSA-N 2-(benzhydrylamino)-1-(5-bromopyridin-2-yl)ethanol Chemical compound C=1C=C(Br)C=NC=1C(O)CNC(C=1C=CC=CC=1)C1=CC=CC=C1 WYCSPSKHHDVQQA-UHFFFAOYSA-N 0.000 description 1
- COZQICWGNCIFTQ-UHFFFAOYSA-N 2-(benzylamino)-1-(2-methyl-4-phenylmethoxyphenyl)ethanol Chemical compound C=1C=C(C(O)CNCC=2C=CC=CC=2)C(C)=CC=1OCC1=CC=CC=C1 COZQICWGNCIFTQ-UHFFFAOYSA-N 0.000 description 1
- ABSFJKBRSIQBQP-UHFFFAOYSA-N 2-(benzylamino)-1-(3-methyl-4-phenylmethoxyphenyl)ethanol Chemical compound CC1=CC(C(O)CNCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=C1 ABSFJKBRSIQBQP-UHFFFAOYSA-N 0.000 description 1
- IMXPVDJTXSLWFX-UHFFFAOYSA-N 2-(benzylamino)-1-(3-phenylmethoxyphenyl)ethanol Chemical compound C=1C=CC(OCC=2C=CC=CC=2)=CC=1C(O)CNCC1=CC=CC=C1 IMXPVDJTXSLWFX-UHFFFAOYSA-N 0.000 description 1
- GZFWXAXTKVREAA-UHFFFAOYSA-N 2-(benzylamino)-1-(4-bromophenyl)ethanol Chemical compound C=1C=C(Br)C=CC=1C(O)CNCC1=CC=CC=C1 GZFWXAXTKVREAA-UHFFFAOYSA-N 0.000 description 1
- KHFDJUATECMKCG-UHFFFAOYSA-N 2-(benzylamino)-1-(4-phenylmethoxyphenyl)ethanol Chemical compound C=1C=C(OCC=2C=CC=CC=2)C=CC=1C(O)CNCC1=CC=CC=C1 KHFDJUATECMKCG-UHFFFAOYSA-N 0.000 description 1
- PVSIPYZLJMUSGZ-UHFFFAOYSA-N 2-(benzylamino)-1-[4-phenylmethoxy-3-(trifluoromethyl)phenyl]ethanol Chemical compound C=1C=C(OCC=2C=CC=CC=2)C(C(F)(F)F)=CC=1C(O)CNCC1=CC=CC=C1 PVSIPYZLJMUSGZ-UHFFFAOYSA-N 0.000 description 1
- CYRIVOKMAGXRNK-UHFFFAOYSA-N 2-[3-chloro-4-[(2-chloro-6-fluorophenyl)methoxy]phenyl]morpholine Chemical compound FC1=CC=CC(Cl)=C1COC1=CC=C(C2OCCNC2)C=C1Cl CYRIVOKMAGXRNK-UHFFFAOYSA-N 0.000 description 1
- NSYLCAIYWNJGGP-UHFFFAOYSA-N 2-[3-chloro-4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholine Chemical compound FC(F)(F)C1=CC=CC=C1COC1=CC=C(C2OCCNC2)C=C1Cl NSYLCAIYWNJGGP-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical class CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical compound C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 description 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 1
- RQXUTROIBRXQLZ-UHFFFAOYSA-N 3-[2-[2-methyl-4-[(4-methylphenyl)methoxy]phenyl]morpholin-4-yl]propanoic acid Chemical compound C1=CC(C)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 RQXUTROIBRXQLZ-UHFFFAOYSA-N 0.000 description 1
- WKEOEDOOQSQNNO-UHFFFAOYSA-N 3-[2-[4-[(4-butylphenyl)methoxy]-2-methylphenyl]morpholin-4-yl]propanoic acid Chemical compound C1=CC(CCCC)=CC=C1COC(C=C1C)=CC=C1C1OCCN(CCC(O)=O)C1 WKEOEDOOQSQNNO-UHFFFAOYSA-N 0.000 description 1
- VLRGXXKFHVJQOL-UHFFFAOYSA-N 3-chloropentane-2,4-dione Chemical compound CC(=O)C(Cl)C(C)=O VLRGXXKFHVJQOL-UHFFFAOYSA-N 0.000 description 1
- WXBKENPITCYRJG-UHFFFAOYSA-N 4-(2-methylmorpholin-2-yl)phenol Chemical compound C=1C=C(O)C=CC=1C1(C)CNCCO1 WXBKENPITCYRJG-UHFFFAOYSA-N 0.000 description 1
- ZYXSFBMPLJLKAR-UHFFFAOYSA-N 4-(4-benzylmorpholin-2-yl)-3-fluorophenol Chemical compound FC1=CC(O)=CC=C1C1OCCN(CC=2C=CC=CC=2)C1 ZYXSFBMPLJLKAR-UHFFFAOYSA-N 0.000 description 1
- UPAHHDRQYIEPTN-UHFFFAOYSA-N 4-(5,5-dimethylmorpholin-2-yl)phenol Chemical compound C1NC(C)(C)COC1C1=CC=C(O)C=C1 UPAHHDRQYIEPTN-UHFFFAOYSA-N 0.000 description 1
- ILMKLPKYWWQWIE-UHFFFAOYSA-N 4-(6,6-dimethylmorpholin-2-yl)phenol Chemical compound O1C(C)(C)CNCC1C1=CC=C(O)C=C1 ILMKLPKYWWQWIE-UHFFFAOYSA-N 0.000 description 1
- YDPOTXGSJPRLNB-UHFFFAOYSA-N 4-(benzotriazol-1-ylmethyl)-2-(4-octoxyphenyl)morpholine Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CN2C3=CC=CC=C3N=N2)C1 YDPOTXGSJPRLNB-UHFFFAOYSA-N 0.000 description 1
- DLGZLIXYVSQGOX-UHFFFAOYSA-N 4-[8-[4-(4-tert-butylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide Chemical compound C1CN(C(C)(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=COC(C(N)=O)=C1 DLGZLIXYVSQGOX-UHFFFAOYSA-N 0.000 description 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 description 1
- GVCLNACSYKYUHP-UHFFFAOYSA-N 4-amino-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine-5-carbothioamide Chemical compound C1=NC(N)=C2C(C(=S)N)=CN(COCCO)C2=N1 GVCLNACSYKYUHP-UHFFFAOYSA-N 0.000 description 1
- VKBJEXJLDLSAIU-UHFFFAOYSA-N 4-benzyl-2,2-dimethyl-6-(4-phenylmethoxyphenyl)morpholine Chemical compound C1C(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)OC(C)(C)CN1CC1=CC=CC=C1 VKBJEXJLDLSAIU-UHFFFAOYSA-N 0.000 description 1
- VEHHTCLJRADNBR-UHFFFAOYSA-N 4-benzyl-2-(2-methyl-4-phenylmethoxyphenyl)morpholine Chemical compound C=1C=C(C2OCCN(CC=3C=CC=CC=3)C2)C(C)=CC=1OCC1=CC=CC=C1 VEHHTCLJRADNBR-UHFFFAOYSA-N 0.000 description 1
- LRIXQBCRCHHBCW-UHFFFAOYSA-N 4-benzyl-2-(3-methyl-4-phenylmethoxyphenyl)morpholine Chemical compound CC1=CC(C2OCCN(CC=3C=CC=CC=3)C2)=CC=C1OCC1=CC=CC=C1 LRIXQBCRCHHBCW-UHFFFAOYSA-N 0.000 description 1
- JGZQCWHMUQSCNK-UHFFFAOYSA-N 4-benzyl-2-(3-phenylmethoxyphenyl)morpholine Chemical compound C=1C=CC=CC=1COC(C=1)=CC=CC=1C(OCC1)CN1CC1=CC=CC=C1 JGZQCWHMUQSCNK-UHFFFAOYSA-N 0.000 description 1
- UFZWHZBVXCKIRM-UHFFFAOYSA-N 4-benzyl-2-(4-phenylmethoxyphenyl)morpholine Chemical compound C=1C=CC=CC=1COC(C=C1)=CC=C1C(OCC1)CN1CC1=CC=CC=C1 UFZWHZBVXCKIRM-UHFFFAOYSA-N 0.000 description 1
- JWIBCPZKSYDSBR-UHFFFAOYSA-N 4-benzyl-2-[3-chloro-4-[(2-chloro-6-fluorophenyl)methoxy]phenyl]morpholine Chemical compound FC1=CC=CC(Cl)=C1COC1=CC=C(C2OCCN(CC=3C=CC=CC=3)C2)C=C1Cl JWIBCPZKSYDSBR-UHFFFAOYSA-N 0.000 description 1
- IURCPMOBXWPERU-UHFFFAOYSA-N 4-benzyl-2-[3-chloro-4-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]morpholine Chemical compound FC(F)(F)C1=CC=CC=C1COC1=CC=C(C2OCCN(CC=3C=CC=CC=3)C2)C=C1Cl IURCPMOBXWPERU-UHFFFAOYSA-N 0.000 description 1
- SHYKYPJXZSNFTA-UHFFFAOYSA-N 4-benzyl-2-[4-phenylmethoxy-3-(trifluoromethyl)phenyl]morpholine Chemical compound FC(F)(F)C1=CC(C2OCCN(CC=3C=CC=CC=3)C2)=CC=C1OCC1=CC=CC=C1 SHYKYPJXZSNFTA-UHFFFAOYSA-N 0.000 description 1
- ZZBKBFJDBGAYEA-UHFFFAOYSA-N 4-benzyl-2-methyl-2-(4-phenylmethoxyphenyl)morpholine Chemical compound C1COC(C)(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)CN1CC1=CC=CC=C1 ZZBKBFJDBGAYEA-UHFFFAOYSA-N 0.000 description 1
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
- 229940073735 4-hydroxy acetophenone Drugs 0.000 description 1
- IAMNVCJECQWBLZ-UHFFFAOYSA-N 4-hydroxy-2-methylacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1C IAMNVCJECQWBLZ-UHFFFAOYSA-N 0.000 description 1
- LXBHHIZIQVZGFN-UHFFFAOYSA-N 4-hydroxy-3-methylacetophenone Chemical compound CC(=O)C1=CC=C(O)C(C)=C1 LXBHHIZIQVZGFN-UHFFFAOYSA-N 0.000 description 1
- FHQRDEDZJIFJAL-UHFFFAOYSA-N 4-phenylmorpholine Chemical compound C1COCCN1C1=CC=CC=C1 FHQRDEDZJIFJAL-UHFFFAOYSA-N 0.000 description 1
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 description 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 description 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 1
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 1
- NJIAKNWTIVDSDA-FQEVSTJZSA-N 7-[4-(1-methylsulfonylpiperidin-4-yl)phenyl]-n-[[(2s)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine Chemical compound C1CN(S(=O)(=O)C)CCC1C1=CC=C(C=2N=C(NC[C@H]3OCCNC3)C3=NC=CN=C3C=2)C=C1 NJIAKNWTIVDSDA-FQEVSTJZSA-N 0.000 description 1
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 1
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- ZQMPVYXXKBCLTJ-UHFFFAOYSA-N BrCC(C1=CC(=CC=C1)OCC1=CC=CC=C1)C(=O)C(CBr)C1=CC(=CC=C1)OCC1=CC=CC=C1 Chemical compound BrCC(C1=CC(=CC=C1)OCC1=CC=CC=C1)C(=O)C(CBr)C1=CC(=CC=C1)OCC1=CC=CC=C1 ZQMPVYXXKBCLTJ-UHFFFAOYSA-N 0.000 description 1
- GMGLGUFSJCMZNT-UHFFFAOYSA-N BrCCCCCC.BrCCCCCC Chemical compound BrCCCCCC.BrCCCCCC GMGLGUFSJCMZNT-UHFFFAOYSA-N 0.000 description 1
- RDEOSOQLFKUNHL-UHFFFAOYSA-N C(C)[NH+](CC)CC.FC(C(=O)[O-])C Chemical class C(C)[NH+](CC)CC.FC(C(=O)[O-])C RDEOSOQLFKUNHL-UHFFFAOYSA-N 0.000 description 1
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 1
- CDZKOUBRAGYRTE-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=CC=C(C=C1)C(CBr)C(=O)C(CBr)C1=CC=C(C=C1)OCC1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)OC1=CC=C(C=C1)C(CBr)C(=O)C(CBr)C1=CC=C(C=C1)OCC1=CC=CC=C1 CDZKOUBRAGYRTE-UHFFFAOYSA-N 0.000 description 1
- 0 C*(CC(c(cc1)ccc1OCc1ccccc1)OC)C(CN)=O Chemical compound C*(CC(c(cc1)ccc1OCc1ccccc1)OC)C(CN)=O 0.000 description 1
- BGGALFIXXQOTPY-NRFANRHFSA-N C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC Chemical compound C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC BGGALFIXXQOTPY-NRFANRHFSA-N 0.000 description 1
- YPFRQZILUODWNI-UHFFFAOYSA-N C=CC.C(C=C)(=O)OC(C)(C)C Chemical compound C=CC.C(C=C)(=O)OC(C)(C)C YPFRQZILUODWNI-UHFFFAOYSA-N 0.000 description 1
- SUWFIANEUPJCTG-UHFFFAOYSA-N CC(C(N(Cc1ccccc1)C1)=O)OC1c(cc1)ccc1OCc1ccccc1 Chemical compound CC(C(N(Cc1ccccc1)C1)=O)OC1c(cc1)ccc1OCc1ccccc1 SUWFIANEUPJCTG-UHFFFAOYSA-N 0.000 description 1
- QWVXMRVZRLVQGL-UHFFFAOYSA-N CC(C)(C(N(Cc1ccccc1)C1)=O)OC1c(cc1)ccc1OCc1ccccc1 Chemical compound CC(C)(C(N(Cc1ccccc1)C1)=O)OC1c(cc1)ccc1OCc1ccccc1 QWVXMRVZRLVQGL-UHFFFAOYSA-N 0.000 description 1
- DPAACIXDTSYZQZ-UHFFFAOYSA-N CC(C)(C)OP(OCCN1CC(c(cc2)ccc2OCc(c(Cl)ccc2)c2Cl)OCC1)(OC(C)(C)C)=O Chemical compound CC(C)(C)OP(OCCN1CC(c(cc2)ccc2OCc(c(Cl)ccc2)c2Cl)OCC1)(OC(C)(C)C)=O DPAACIXDTSYZQZ-UHFFFAOYSA-N 0.000 description 1
- KDUNMLRPPVCIGP-UHFFFAOYSA-N CC(C)[Zn]C(C)C Chemical compound CC(C)[Zn]C(C)C KDUNMLRPPVCIGP-UHFFFAOYSA-N 0.000 description 1
- ZNGTZGQYHKMYRE-UHFFFAOYSA-N CC(C1=C(C=C(C=C1)O)C(F)(F)F)C(=O)C(C)C2=C(C=C(C=C2)O)C(F)(F)F Chemical compound CC(C1=C(C=C(C=C1)O)C(F)(F)F)C(=O)C(C)C2=C(C=C(C=C2)O)C(F)(F)F ZNGTZGQYHKMYRE-UHFFFAOYSA-N 0.000 description 1
- MOEMGDOFOQTHAW-UHFFFAOYSA-N CC1=C(C=CC(=C1)C(C)C(=O)C(C)C2=CC(=C(C=C2)OCC3=CC=CC=C3)C)OCC4=CC=CC=C4 Chemical compound CC1=C(C=CC(=C1)C(C)C(=O)C(C)C2=CC(=C(C=C2)OCC3=CC=CC=C3)C)OCC4=CC=CC=C4 MOEMGDOFOQTHAW-UHFFFAOYSA-N 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- GMUUFOQOWWFZSA-UHFFFAOYSA-N CCCCCCCCOc(cc1)ccc1C(CBr)=O Chemical compound CCCCCCCCOc(cc1)ccc1C(CBr)=O GMUUFOQOWWFZSA-UHFFFAOYSA-N 0.000 description 1
- LQZQYRSIFPOBMC-UHFFFAOYSA-N CCCCCCCCOc1ccc(C2OCCN(CC(C(OCC)=O)(F)F)C2)cc1 Chemical compound CCCCCCCCOc1ccc(C2OCCN(CC(C(OCC)=O)(F)F)C2)cc1 LQZQYRSIFPOBMC-UHFFFAOYSA-N 0.000 description 1
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 description 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
- DBXRZFCFVAGRMF-UHFFFAOYSA-N CCc1cc(Cl)c(COc2ccc(C3OCCN(CCC(OC(C)(C)C)=O)C3)cc2)c(Cl)c1 Chemical compound CCc1cc(Cl)c(COc2ccc(C3OCCN(CCC(OC(C)(C)C)=O)C3)cc2)c(Cl)c1 DBXRZFCFVAGRMF-UHFFFAOYSA-N 0.000 description 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WNVZZBOZAPOZDX-UHFFFAOYSA-N Clc(cccc1Cl)c1OCc1ccc(C2OCCN(Cc3ccccc3)C2)cc1 Chemical compound Clc(cccc1Cl)c1OCc1ccc(C2OCCN(Cc3ccccc3)C2)cc1 WNVZZBOZAPOZDX-UHFFFAOYSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 229940127007 Compound 39 Drugs 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 201000011240 Frontotemporal dementia Diseases 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 1
- 101000693269 Homo sapiens Sphingosine 1-phosphate receptor 3 Proteins 0.000 description 1
- 101000653759 Homo sapiens Sphingosine 1-phosphate receptor 5 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001289721 Lethe Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 238000006957 Michael reaction Methods 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 1
- LIMFPAAAIVQRRD-BCGVJQADSA-N N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine Chemical compound F[C@H]1CN(CC[C@H]1OC)C1=NC=CC(=N1)NC=1N=CC2=C(C=CC(=C2C=1)C(C)C)N1[C@@H]([C@H](C1)CS(=O)(=O)C)C LIMFPAAAIVQRRD-BCGVJQADSA-N 0.000 description 1
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 description 1
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 238000006411 Negishi coupling reaction Methods 0.000 description 1
- XDGXGQFKQWNMKA-UHFFFAOYSA-N O1OBCC1.CCCCC Chemical compound O1OBCC1.CCCCC XDGXGQFKQWNMKA-UHFFFAOYSA-N 0.000 description 1
- 239000005922 Phosphane Substances 0.000 description 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 description 1
- 208000024571 Pick disease Diseases 0.000 description 1
- 101150043606 S1pr5 gene Proteins 0.000 description 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229910007926 ZrCl Inorganic materials 0.000 description 1
- 229910007932 ZrCl4 Inorganic materials 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- DRBWRJPFNOBNIO-KOLCDFICSA-N [(2r)-1-[(2r)-2-(pyridine-4-carbonylamino)propanoyl]pyrrolidin-2-yl]boronic acid Chemical compound N([C@H](C)C(=O)N1[C@@H](CCC1)B(O)O)C(=O)C1=CC=NC=C1 DRBWRJPFNOBNIO-KOLCDFICSA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- GIVCJIVGQHCKPY-UHFFFAOYSA-N [4-(2-bromoacetyl)-2-chlorophenyl] methanesulfonate Chemical compound CS(=O)(=O)OC1=CC=C(C(=O)CBr)C=C1Cl GIVCJIVGQHCKPY-UHFFFAOYSA-N 0.000 description 1
- PPSMHIAOUSGXLJ-UHFFFAOYSA-N [4-(2-bromoacetyl)-3-fluorophenyl] methanesulfonate Chemical compound CS(=O)(=O)OC1=CC=C(C(=O)CBr)C(F)=C1 PPSMHIAOUSGXLJ-UHFFFAOYSA-N 0.000 description 1
- GIYSMNIECFVOIR-UHFFFAOYSA-N [4-[2-(benzylamino)-1-hydroxyethyl]-2-chlorophenyl] methanesulfonate Chemical compound C1=C(Cl)C(OS(=O)(=O)C)=CC=C1C(O)CNCC1=CC=CC=C1 GIYSMNIECFVOIR-UHFFFAOYSA-N 0.000 description 1
- CKAUMMRGMHIPTN-UHFFFAOYSA-N [4-[2-(benzylamino)-1-hydroxyethyl]-3-fluorophenyl] methanesulfonate Chemical compound FC1=CC(OS(=O)(=O)C)=CC=C1C(O)CNCC1=CC=CC=C1 CKAUMMRGMHIPTN-UHFFFAOYSA-N 0.000 description 1
- JAZCEXBNIYKZDI-UHFFFAOYSA-N [Ir+] Chemical class [Ir+] JAZCEXBNIYKZDI-UHFFFAOYSA-N 0.000 description 1
- RMLHVYNAGVXKKC-UHFFFAOYSA-N [SH2]=N.C(F)(F)F Chemical compound [SH2]=N.C(F)(F)F RMLHVYNAGVXKKC-UHFFFAOYSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 230000002902 bimodal effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- PRNFLFIICMGARJ-UHFFFAOYSA-N carbonochloridic acid;pyridine Chemical compound OC(Cl)=O.C1=CC=NC=C1 PRNFLFIICMGARJ-UHFFFAOYSA-N 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000023402 cell communication Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- ARQRPTNYUOLOGH-UHFFFAOYSA-N chcl3 chloroform Chemical compound ClC(Cl)Cl.ClC(Cl)Cl ARQRPTNYUOLOGH-UHFFFAOYSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 229940127573 compound 38 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 229940126545 compound 53 Drugs 0.000 description 1
- 229940127113 compound 57 Drugs 0.000 description 1
- 229940125900 compound 59 Drugs 0.000 description 1
- 229940126179 compound 72 Drugs 0.000 description 1
- GCUVBACNBHGZRS-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-2,4-dien-1-yl(diphenyl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1cc[c-](c1)P(c1ccccc1)c1ccccc1 GCUVBACNBHGZRS-UHFFFAOYSA-N 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- VKFAUCPBMAGVRG-UHFFFAOYSA-N dipivefrin hydrochloride Chemical compound [Cl-].C[NH2+]CC(O)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1 VKFAUCPBMAGVRG-UHFFFAOYSA-N 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical class CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000009762 endothelial cell differentiation Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
- SDJHDRMYZQFJJO-UHFFFAOYSA-N ethanethioic s-acid;potassium Chemical compound [K].CC(S)=O SDJHDRMYZQFJJO-UHFFFAOYSA-N 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 description 1
- IRSJDVYTJUCXRV-UHFFFAOYSA-N ethyl 2-bromo-2,2-difluoroacetate Chemical compound CCOC(=O)C(F)(F)Br IRSJDVYTJUCXRV-UHFFFAOYSA-N 0.000 description 1
- PPRAWWBOUOBAON-UHFFFAOYSA-N ethyl 2-bromo-2-(4-bromophenyl)acetate Chemical compound CCOC(=O)C(Br)C1=CC=C(Br)C=C1 PPRAWWBOUOBAON-UHFFFAOYSA-N 0.000 description 1
- ODMITNOQNBVSQG-UHFFFAOYSA-N ethyl 2-fluoropropanoate Chemical class CCOC(=O)C(C)F ODMITNOQNBVSQG-UHFFFAOYSA-N 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- AMGWDYLEMSMUIO-UHFFFAOYSA-N ethyl 5-bromo-2-chlorobenzoate Chemical compound CCOC(=O)C1=CC(Br)=CC=C1Cl AMGWDYLEMSMUIO-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- WUOIAOOSKMHJOV-UHFFFAOYSA-N ethyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(CC)C1=CC=CC=C1 WUOIAOOSKMHJOV-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000002868 homogeneous time resolved fluorescence Methods 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- KJRFTNVYOAGTHK-UHFFFAOYSA-N methyl 3-hydroxy-2,2-dimethylpropanoate Chemical compound COC(=O)C(C)(C)CO KJRFTNVYOAGTHK-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- VJNDZIJEKQZBPZ-UHFFFAOYSA-N morpholine;thiourea Chemical compound NC(N)=S.C1COCCN1 VJNDZIJEKQZBPZ-UHFFFAOYSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 description 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 1
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- WXVUCMFEGJUVTN-UHFFFAOYSA-N phenyl methanesulfonate Chemical compound CS(=O)(=O)OC1=CC=CC=C1 WXVUCMFEGJUVTN-UHFFFAOYSA-N 0.000 description 1
- 229910000064 phosphane Inorganic materials 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 101150024819 s1pr1 gene Proteins 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 230000006886 spatial memory Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000004500 stellate cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012799 strong cation exchange Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- SOIPRMMDUBLIQW-UHFFFAOYSA-N tert-butyl 2,2-dimethyl-3-[2-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CC(C)(C)C(=O)OC(C)(C)C)C1 SOIPRMMDUBLIQW-UHFFFAOYSA-N 0.000 description 1
- AOAUVSWQCBUBET-UHFFFAOYSA-N tert-butyl 3-[2,2-dimethyl-6-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OC(C)(C)CN(CCC(=O)OC(C)(C)C)C1 AOAUVSWQCBUBET-UHFFFAOYSA-N 0.000 description 1
- JTTUCNJVNQCWFA-UHFFFAOYSA-N tert-butyl 3-[2-(2-fluoro-4-hydroxyphenyl)morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=C(O)C=C1F JTTUCNJVNQCWFA-UHFFFAOYSA-N 0.000 description 1
- DUGPNCMEMFNPED-UHFFFAOYSA-N tert-butyl 3-[2-(3-hydroxyphenyl)morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=CC(O)=C1 DUGPNCMEMFNPED-UHFFFAOYSA-N 0.000 description 1
- YOCSMYPGJDACKT-UHFFFAOYSA-N tert-butyl 3-[2-(3-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound CCCCCCCCOC1=CC=CC(C2OCCN(CCC(=O)OC(C)(C)C)C2)=C1 YOCSMYPGJDACKT-UHFFFAOYSA-N 0.000 description 1
- UKRNWAAKKRHCOW-UHFFFAOYSA-N tert-butyl 3-[2-(3-phenylmethoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=CC(OCC=2C=CC=CC=2)=C1 UKRNWAAKKRHCOW-UHFFFAOYSA-N 0.000 description 1
- DDYSNTBCQKDBJY-UHFFFAOYSA-N tert-butyl 3-[2-(4-hexoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCC)=CC=C1C1OCCN(CCC(=O)OC(C)(C)C)C1 DDYSNTBCQKDBJY-UHFFFAOYSA-N 0.000 description 1
- SKYCAIVWMXUZBX-UHFFFAOYSA-N tert-butyl 3-[2-(4-hydroxy-3-methylphenyl)morpholin-4-yl]propanoate Chemical compound C1=C(O)C(C)=CC(C2OCCN(CCC(=O)OC(C)(C)C)C2)=C1 SKYCAIVWMXUZBX-UHFFFAOYSA-N 0.000 description 1
- NRNHWRMEGBAKEK-UHFFFAOYSA-N tert-butyl 3-[2-(4-hydroxyphenyl)-2-methylmorpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1(C)C1=CC=C(O)C=C1 NRNHWRMEGBAKEK-UHFFFAOYSA-N 0.000 description 1
- DRHCYNJJJGVQIB-UHFFFAOYSA-N tert-butyl 3-[2-(4-hydroxyphenyl)-5,5-dimethylmorpholin-4-yl]propanoate Chemical compound O1CC(C)(C)N(CCC(=O)OC(C)(C)C)CC1C1=CC=C(O)C=C1 DRHCYNJJJGVQIB-UHFFFAOYSA-N 0.000 description 1
- DNTJJTMGLKWBKK-UHFFFAOYSA-N tert-butyl 3-[2-(4-hydroxyphenyl)-5-oxomorpholin-4-yl]propanoate Chemical compound O1CC(=O)N(CCC(=O)OC(C)(C)C)CC1C1=CC=C(O)C=C1 DNTJJTMGLKWBKK-UHFFFAOYSA-N 0.000 description 1
- PFWIIXGLZKBVSK-UHFFFAOYSA-N tert-butyl 3-[2-(4-octoxyphenyl)-5-oxomorpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCC(=O)N(CCC(=O)OC(C)(C)C)C1 PFWIIXGLZKBVSK-UHFFFAOYSA-N 0.000 description 1
- KOFZXRXNOQTKFL-UHFFFAOYSA-N tert-butyl 3-[2-(4-phenylmethoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C(C=C1)=CC=C1OCC1=CC=CC=C1 KOFZXRXNOQTKFL-UHFFFAOYSA-N 0.000 description 1
- WMLYTBDQEJIYSS-UHFFFAOYSA-N tert-butyl 3-[2-(5-hydroxypyridin-2-yl)morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=C(O)C=N1 WMLYTBDQEJIYSS-UHFFFAOYSA-N 0.000 description 1
- JCJVMLSQLDMTLW-UHFFFAOYSA-N tert-butyl 3-[2-[4-hydroxy-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=C(O)C=C1C(F)(F)F JCJVMLSQLDMTLW-UHFFFAOYSA-N 0.000 description 1
- DFYNMQIZUQMPJY-UHFFFAOYSA-N tert-butyl 3-[2-[4-hydroxy-3-(trifluoromethyl)phenyl]morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC(C)(C)C)CCOC1C1=CC=C(O)C(C(F)(F)F)=C1 DFYNMQIZUQMPJY-UHFFFAOYSA-N 0.000 description 1
- IGSJWIXAGPCTLR-UHFFFAOYSA-N tert-butyl 3-[2-[4-octoxy-2-(trifluoromethyl)phenyl]morpholin-4-yl]propanoate Chemical compound FC(F)(F)C1=CC(OCCCCCCCC)=CC=C1C1OCCN(CCC(=O)OC(C)(C)C)C1 IGSJWIXAGPCTLR-UHFFFAOYSA-N 0.000 description 1
- DAOWCIRWWYQWAZ-UHFFFAOYSA-N tert-butyl 3-[2-methyl-2-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1(C)OCCN(CCC(=O)OC(C)(C)C)C1 DAOWCIRWWYQWAZ-UHFFFAOYSA-N 0.000 description 1
- VVVVFUZHUNZKBC-UHFFFAOYSA-N tert-butyl 3-[5,5-dimethyl-2-(4-octoxyphenyl)morpholin-4-yl]propanoate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1OCC(C)(C)N(CCC(=O)OC(C)(C)C)C1 VVVVFUZHUNZKBC-UHFFFAOYSA-N 0.000 description 1
- ADIVKIHMCJESQR-UHFFFAOYSA-N tert-butyl 3-[6-(4-hydroxyphenyl)-2,2-dimethylmorpholin-4-yl]propanoate Chemical compound O1C(C)(C)CN(CCC(=O)OC(C)(C)C)CC1C1=CC=C(O)C=C1 ADIVKIHMCJESQR-UHFFFAOYSA-N 0.000 description 1
- KMBJYRVRYVUHCJ-UHFFFAOYSA-N tert-butyl 3-chloro-2,2-dimethylpropanoate Chemical compound CC(C)(C)OC(=O)C(C)(C)CCl KMBJYRVRYVUHCJ-UHFFFAOYSA-N 0.000 description 1
- QMGIVCYNYDJUHM-UHFFFAOYSA-N tert-butyl 4-[2-(4-hexoxyphenyl)morpholin-4-yl]butanoate Chemical compound C1=CC(OCCCCCC)=CC=C1C1OCCN(CCCC(=O)OC(C)(C)C)C1 QMGIVCYNYDJUHM-UHFFFAOYSA-N 0.000 description 1
- HJEZRYIJNHAIGY-UHFFFAOYSA-N tert-butyl 4-bromobutanoate Chemical compound CC(C)(C)OC(=O)CCCBr HJEZRYIJNHAIGY-UHFFFAOYSA-N 0.000 description 1
- WGLLSSPDPJPLOR-UHFFFAOYSA-N tetramethylethylene Natural products CC(C)=C(C)C WGLLSSPDPJPLOR-UHFFFAOYSA-N 0.000 description 1
- PHCBRBWANGJMHS-UHFFFAOYSA-J tetrasodium;disulfate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O PHCBRBWANGJMHS-UHFFFAOYSA-J 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- DUYAAUVXQSMXQP-UHFFFAOYSA-M thioacetate Chemical compound CC([S-])=O DUYAAUVXQSMXQP-UHFFFAOYSA-M 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 230000001519 thymoleptic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- NMLXKNNXODLJIN-UHFFFAOYSA-M zinc;carbanide;chloride Chemical compound [CH3-].[Zn+]Cl NMLXKNNXODLJIN-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09169075.0 | 2009-08-31 | ||
EP09169075 | 2009-08-31 | ||
PCT/EP2010/062552 WO2011023795A1 (en) | 2009-08-31 | 2010-08-27 | (thio)morpholine derivatives as s1p modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102548976A true CN102548976A (zh) | 2012-07-04 |
CN102548976B CN102548976B (zh) | 2015-09-09 |
Family
ID=41361253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080042681.8A Expired - Fee Related CN102548976B (zh) | 2009-08-31 | 2010-08-27 | 作为s1p调节剂的(硫)吗啉衍生物 |
Country Status (25)
Country | Link |
---|---|
US (2) | US9045441B2 (zh) |
EP (1) | EP2473490B1 (zh) |
JP (1) | JP5933436B2 (zh) |
KR (1) | KR101767882B1 (zh) |
CN (1) | CN102548976B (zh) |
AR (1) | AR077969A1 (zh) |
AU (1) | AU2010288477B8 (zh) |
CA (1) | CA2772169C (zh) |
CR (1) | CR20120153A (zh) |
DO (1) | DOP2012000053A (zh) |
EC (1) | ECSP12011695A (zh) |
ES (1) | ES2452550T3 (zh) |
HK (1) | HK1172620A1 (zh) |
IL (1) | IL218208A (zh) |
MX (1) | MX2012002534A (zh) |
NZ (1) | NZ598300A (zh) |
PE (1) | PE20121280A1 (zh) |
PL (1) | PL2473490T3 (zh) |
RU (1) | RU2557233C2 (zh) |
SG (1) | SG178902A1 (zh) |
TW (1) | TW201113263A (zh) |
UA (1) | UA106994C2 (zh) |
UY (1) | UY32858A (zh) |
WO (1) | WO2011023795A1 (zh) |
ZA (1) | ZA201201446B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105949142A (zh) * | 2016-05-21 | 2016-09-21 | 南华大学 | 具有抗抑郁活性的单一手性化合物及其制备方法和应用 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR077969A1 (es) | 2009-08-31 | 2011-10-05 | Abbott Healthcare Products Bv | Derivados de (tio)morfolina comomoduladores de s1p |
TWI522361B (zh) | 2010-07-09 | 2016-02-21 | 艾伯維公司 | 作為s1p調節劑的稠合雜環衍生物 |
TW201206893A (en) * | 2010-07-09 | 2012-02-16 | Abbott Healthcare Products Bv | Bisaryl (thio) morpholine derivatives as S1P modulators |
TWI543984B (zh) | 2010-07-09 | 2016-08-01 | 艾伯維公司 | 作為s1p調節劑的螺-哌啶衍生物 |
US8802673B2 (en) * | 2011-03-24 | 2014-08-12 | Hoffmann-La Roche Inc | Heterocyclic amine derivatives |
US9029370B2 (en) * | 2011-06-10 | 2015-05-12 | Hoffmann-La Roche Inc. | Substituted benzamide derivatives |
MX2015005721A (es) * | 2012-11-07 | 2015-09-08 | Hoffmann La Roche | Derivados de pirazina. |
US9850206B2 (en) | 2012-11-20 | 2017-12-26 | Biogen Ma Inc. | S1P and/or ATX modulating agents |
CN114728982A (zh) | 2019-10-31 | 2022-07-08 | 逃逸生物有限公司 | 固体形式的s1p-受体调节剂 |
AR127592A1 (es) * | 2021-11-08 | 2024-02-07 | Hoffmann La Roche | Hidrogenación catalítica de nitrocompuestos aromáticos |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004111021A1 (en) * | 2003-06-12 | 2004-12-23 | Btg International Limited | Cyclic hydroxylamine as psychoactive compounds |
US20050187251A1 (en) * | 2003-10-14 | 2005-08-25 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
WO2006047159A1 (en) * | 2004-10-22 | 2006-05-04 | Agrinomics Llc | Generation of plants with altered oil content |
CN1950348A (zh) * | 2004-04-30 | 2007-04-18 | 沃尼尔·朗伯有限责任公司 | 治疗中枢神经***障碍的取代的吗啉化合物 |
CN1950089A (zh) * | 2004-04-30 | 2007-04-18 | 辉瑞大药厂 | 吗啉化合物 |
CN101490017A (zh) * | 2006-02-28 | 2009-07-22 | 海利空医疗公司 | 作为pde4抑制剂的用于治疗的哌嗪类 |
CN101511783A (zh) * | 2006-09-08 | 2009-08-19 | 诺瓦提斯公司 | 用于治疗淋巴细胞相互作用介导的疾病的n-联芳(杂)芳基磺酰胺衍生物 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH072848A (ja) * | 1993-04-23 | 1995-01-06 | Sankyo Co Ltd | モルホリンおよびチオモルホリン誘導体 |
JP4152002B2 (ja) * | 1996-08-27 | 2008-09-17 | 興和創薬株式会社 | 2−フェニルモルホリン−5−オン誘導体およびそれを含む医薬組成物 |
US6380387B1 (en) | 1999-12-06 | 2002-04-30 | Hoffmann-La Roche Inc. | 4-Pyrimidinyl-n-acyl-l phenylalanines |
CA2406685C (en) | 2000-04-21 | 2006-10-31 | Shionogi & Co., Ltd. | Oxadiazole derivatives having anticancer effects |
JP4947406B2 (ja) * | 2003-08-29 | 2012-06-06 | 小野薬品工業株式会社 | S1p受容体結合能を有する化合物およびその医薬用途 |
RU2390519C2 (ru) * | 2003-08-29 | 2010-05-27 | Оно Фармасьютикал Ко., Лтд. | Соединение, способное к связыванию с рецептором s1p, и его фармацевтическое применение |
GB0329498D0 (en) * | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
TW200538433A (en) * | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
CN101043887A (zh) * | 2004-10-22 | 2007-09-26 | 默克公司 | 用作s1p受体激动剂的2-(芳基)氮杂环甲基羧酸酯、磺酸酯、膦酸酯、次膦酸酯和杂环化合物 |
ES2338716T3 (es) | 2006-01-27 | 2010-05-11 | F.Hoffmann-La Roche Ag | Uso de derivados de 4-imidazol para trastornos del snc. |
WO2007085557A2 (en) | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of substituted 2-imidazole of imidazoline derivatives |
BRPI0720043A2 (pt) * | 2006-12-15 | 2014-01-07 | Abbott Lab | Composto oxadiazol |
EA200901030A1 (ru) * | 2007-02-02 | 2010-02-26 | Новартис Аг | Антагонист хроменового рецептора s1p1 |
AR077969A1 (es) | 2009-08-31 | 2011-10-05 | Abbott Healthcare Products Bv | Derivados de (tio)morfolina comomoduladores de s1p |
CN101812058B (zh) * | 2010-04-13 | 2012-03-21 | 湖南大学 | 吲哚美辛2-芳基吗啉乙酯及其制备方法与应用 |
-
2010
- 2010-08-26 AR ARP100103116A patent/AR077969A1/es unknown
- 2010-08-26 UY UY0001032858A patent/UY32858A/es not_active Application Discontinuation
- 2010-08-27 RU RU2012112477/04A patent/RU2557233C2/ru not_active IP Right Cessation
- 2010-08-27 JP JP2012526075A patent/JP5933436B2/ja not_active Expired - Fee Related
- 2010-08-27 KR KR1020127008115A patent/KR101767882B1/ko active IP Right Grant
- 2010-08-27 WO PCT/EP2010/062552 patent/WO2011023795A1/en active Application Filing
- 2010-08-27 TW TW099128939A patent/TW201113263A/zh unknown
- 2010-08-27 MX MX2012002534A patent/MX2012002534A/es active IP Right Grant
- 2010-08-27 SG SG2012013793A patent/SG178902A1/en unknown
- 2010-08-27 UA UAA201203923A patent/UA106994C2/uk unknown
- 2010-08-27 ES ES10745659.2T patent/ES2452550T3/es active Active
- 2010-08-27 CA CA2772169A patent/CA2772169C/en not_active Expired - Fee Related
- 2010-08-27 EP EP10745659.2A patent/EP2473490B1/en active Active
- 2010-08-27 AU AU2010288477A patent/AU2010288477B8/en not_active Ceased
- 2010-08-27 NZ NZ598300A patent/NZ598300A/xx not_active IP Right Cessation
- 2010-08-27 CN CN201080042681.8A patent/CN102548976B/zh not_active Expired - Fee Related
- 2010-08-27 PE PE2012000276A patent/PE20121280A1/es not_active Application Discontinuation
- 2010-08-27 US US13/393,497 patent/US9045441B2/en not_active Expired - Fee Related
- 2010-08-27 PL PL10745659T patent/PL2473490T3/pl unknown
-
2012
- 2012-02-20 IL IL218208A patent/IL218208A/en not_active IP Right Cessation
- 2012-02-27 ZA ZA2012/01446A patent/ZA201201446B/en unknown
- 2012-02-27 EC ECSP12011695 patent/ECSP12011695A/es unknown
- 2012-02-29 DO DO2012000053A patent/DOP2012000053A/es unknown
- 2012-03-27 CR CR20120153A patent/CR20120153A/es unknown
- 2012-12-27 HK HK12113470.8A patent/HK1172620A1/zh not_active IP Right Cessation
-
2015
- 2015-03-30 US US14/673,614 patent/US9273017B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004111021A1 (en) * | 2003-06-12 | 2004-12-23 | Btg International Limited | Cyclic hydroxylamine as psychoactive compounds |
US20050187251A1 (en) * | 2003-10-14 | 2005-08-25 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
CN1950348A (zh) * | 2004-04-30 | 2007-04-18 | 沃尼尔·朗伯有限责任公司 | 治疗中枢神经***障碍的取代的吗啉化合物 |
CN1950089A (zh) * | 2004-04-30 | 2007-04-18 | 辉瑞大药厂 | 吗啉化合物 |
WO2006047159A1 (en) * | 2004-10-22 | 2006-05-04 | Agrinomics Llc | Generation of plants with altered oil content |
CN101490017A (zh) * | 2006-02-28 | 2009-07-22 | 海利空医疗公司 | 作为pde4抑制剂的用于治疗的哌嗪类 |
CN101511783A (zh) * | 2006-09-08 | 2009-08-19 | 诺瓦提斯公司 | 用于治疗淋巴细胞相互作用介导的疾病的n-联芳(杂)芳基磺酰胺衍生物 |
Non-Patent Citations (2)
Title |
---|
胡艾希,等: "盐酸2-芳基吗琳的合成与表征", 《湖南大学学报(自然科学版)》 * |
胡艾希,等: "萘普生2-芳基吗啉乙酯的合成及其对环氧合酶-2 的抑制活性", 《化学学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105949142A (zh) * | 2016-05-21 | 2016-09-21 | 南华大学 | 具有抗抑郁活性的单一手性化合物及其制备方法和应用 |
CN105949142B (zh) * | 2016-05-21 | 2018-03-27 | 南华大学 | 具有抗抑郁活性的单一手性化合物及其制备方法和应用 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102548976B (zh) | 作为s1p调节剂的(硫)吗啉衍生物 | |
CN103097364B (zh) | 作为s1p调节剂的螺-哌啶衍生物 | |
ES2588743T3 (es) | Compuestos químicos | |
CN101641360B (zh) | 哌嗪类衍生物,其制备方法及其在医药上的应用 | |
JP5218737B2 (ja) | スフィンゴシン−1−リン酸結合阻害物質 | |
US20070225257A1 (en) | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] Phosphonic Acid and Methods of Use Thereof | |
CN101151265A (zh) | 二肽基肽酶-ⅳ抑制化合物,其制备方法,以及含有该化合物作为活性剂的药物组合物 | |
CN104334554B (zh) | 作为bace1抑制剂的5‑氨基[1,4]噻嗪类 | |
TW201348199A (zh) | 補體路徑調節劑及其用途 | |
CN103080096B (zh) | 作为s1p调节剂的双芳基(硫代)吗啉衍生物 | |
CN103068827A (zh) | 作为s1p调节剂的稠合杂环衍生物 | |
CN101939311A (zh) | 对毒蕈碱受体具有亲和力的杂环类化合物 | |
CN107074780A (zh) | 用于生产嘧啶‑1‑醇化合物及其中间体的方法 | |
EP2483257B1 (en) | 2,3,4-benzothiadiazepine-2,2-dioxide derivatives | |
KR101817925B1 (ko) | 치환된 2-(크로만-6-일옥시)-티아졸 및 약제로서의 이의 용도 | |
CN115836063A (zh) | 作为运铁素(ferroportin)抑制剂的环烷基嘧啶 | |
CN102076678A (zh) | 作为bace抑制剂的具有氨基苄基取代基的环砜类化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YABOVI BAHAMAS LTD. Free format text: FORMER OWNER: ABBOTT HEALTHCARE PRODUCTS B.V. Effective date: 20130705 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130705 Address after: Bahamian archipelago, Nassau Applicant after: AbbVie Bahamas Ltd. Address before: Holland Weesp Applicant before: ABBOTT HEALTHCARE PRODUCTS B.V. |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: W.I. Ivermabuck Inventor after: Terwel Louise Heir Of Reinders Inventor after: Mons Harmen Inventor after: A. Stoyt Inventor after: E. Longken Inventor after: Kam Van Der Elizabeth Inventor after: Frankena Jurjen Inventor after: A. Hobson Inventor before: W.I. Ivermabuck Inventor before: Terwel Louise Heir Of Reinders Inventor before: Mons Harmen Inventor before: A. Stoyt Inventor before: E. Longken Inventor before: Kam Van Der Elizabeth Inventor before: Frankena Jurjen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: IWEMA BAKKER WOUTER I. COOLEN HEIN K. A. C. HARMEN MONS AXEL STOIT ERIC RONKEN ELIZABETH KAM VAN DER JURJEN FRANKENA TO: IWEMA BAKKER WOUTER I. COOLEN HEIN K. A. C. HARMEN MONS AXEL STOIT ERIC RONKEN ELIZABETH KAM VAN DER JURJEN FRANKENA HOBSON ADRIAN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1172620 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150909 Termination date: 20210827 |
|
CF01 | Termination of patent right due to non-payment of annual fee |